TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-71384	Ethanol oxidation	3.8898095622068e-06	-12.4571503572632	12	5	0.021551724137931	232	10287	125,130,127,216,126	ADH1B,ADH6,ADH4,ALDH1A1,ADH1C
R-HSA-397014	Muscle contraction	1.45846755442236e-05	-11.1355392007457	204	16	0.0689655172413793	232	10287	775,4638,482,7136,25802,4634,7140,6327,6329,6326,816,10398,89822,4632,60598,6546	CACNA1C,MYLK,ATP1B2,TNNI2,LMOD1,MYL3,TNNT3,SCN2B,SCN4A,SCN2A,CAMK2B,MYL9,KCNK17,MYL1,KCNK15,SLC8A1
R-HSA-211945	Phase 1 - Functionalization of compounds	3.32859552425366e-05	-10.3103750144339	109	11	0.0474137931034483	232	10287	5740,126,125,66002,216,64757,2326,130,2327,51302,127	PTGIS,ADH1C,ADH1B,CYP4F12,ALDH1A1,MARC1,FMO1,ADH6,FMO2,CYP39A1,ADH4
R-HSA-5632681	Ligand-receptor interactions	0.000583153756478746	-7.44705967314558	8	3	0.0129310344827586	232	10287	64399,2619,3549	HHIP,GAS1,IHH
R-HSA-418346	Platelet homeostasis	0.00100797745100285	-6.89980947962003	91	8	0.0344827586206897	232	10287	5136,2788,338,6546,8654,9127,5023,5593	PDE1A,GNG7,APOB,SLC8A1,PDE5A,P2RX6,P2RX1,PRKG2
R-HSA-382551	Transmembrane transport of small molecules	0.00131970617832526	-6.63034615933901	677	28	0.120689655172414	232	10287	816,41,55283,2030,55089,121601,30061,1188,53919,22802,10991,23539,5172,107,6546,5244,6508,225,79895,6563,25769,55867,364,360,482,8001,10396,2788	CAMK2B,ASIC1,MCOLN3,SLC29A1,SLC38A4,ANO4,SLC40A1,CLCNKB,SLCO1C1,CLCA4,SLC38A3,SLC16A8,SLC26A4,ADCY1,SLC8A1,ABCB4,SLC4A3,ABCD2,ATP8B4,SLC14A1,SLC24A2,SLC22A11,AQP7,AQP3,ATP1B2,GLRA3,ATP8A1,GNG7
R-HSA-4641263	Regulation of FZD by ubiquitination	0.00133935188155425	-6.61556945250752	22	4	0.0172413793103448	232	10287	8549,343637,8325,340419	LGR5,RSPO4,FZD8,RSPO2
R-HSA-217271	FMO oxidises nucleophiles	0.00149679580269206	-6.50442858719589	3	2	0.00862068965517241	232	10287	2326,2327	FMO1,FMO2
R-HSA-211859	Biological oxidations	0.0015531097074271	-6.46749609505236	222	13	0.0560344827586207	232	10287	64757,2326,51302,127,130,2327,2946,5740,126,2953,216,125,66002	MARC1,FMO1,CYP39A1,ADH4,ADH6,FMO2,GSTM2,PTGIS,ADH1C,GSTT2,ALDH1A1,ADH1B,CYP4F12
R-HSA-1430728	Metabolism	0.00244973594034748	-6.01177503968413	2158	67	0.288793103448276	232	10287	126,51477,5244,415,2946,2593,125,29881,374569,54511,5649,2953,5105,5166,151742,1490,64757,51196,107,127,23539,5295,130,375775,5740,147323,129807,5053,5169,2326,2788,5224,1149,760,33,788,7069,6382,3158,26289,338,4958,1757,5167,54,162466,775,7351,113026,57571,122618,8908,948,5260,216,51171,11001,165679,5330,2327,117245,10840,5593,66002,55825,2875,51302	ADH1C,ISYNA1,ABCB4,ARSE,GSTM2,GAMT,ADH1B,NPC1L1,ASPG,HMGCLL1,RELN,GSTT2,PCK1,PDK4,PPM1L,CCN2,MARC1,PLCE1,ADCY1,ADH4,SLC16A8,PIK3R1,ADH6,PNPLA7,PTGIS,STARD6,NEU4,PAH,ENPP3,FMO1,GNG7,PGAM2,CIDEA,CA2,ACADL,SLC25A20,THRSP,SDC1,HMGCS2,AK5,APOB,OMD,SARDH,ENPP1,ACP5,PHOSPHO1,CACNA1C,UCP2,PLCD3,CARNS1,PLD4,GYG2,CD36,PHKG1,ALDH1A1,HSD17B14,SLC27A2,SPTSSB,PLCB2,FMO2,PLAAT5,ALDH1L1,PRKG2,CYP4F12,PECR,GPT,CYP39A1
R-HSA-2029485	Role of phospholipids in phagocytosis	0.00255070480420902	-5.97138556419407	26	4	0.0172413793103448	232	10287	2209,2214,122618,5295	FCGR1A,FCGR3A,PLD4,PIK3R1
R-HSA-3781865	Diseases of glycosylation	0.00300900538896957	-5.80614569038549	85	7	0.0301724137931034	232	10287	7057,6382,143662,4958,9719,10417,157869	THBS1,SDC1,MUC15,OMD,ADAMTSL2,SPON2,SBSPON
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.00337246131308862	-5.69211244123397	28	4	0.0172413793103448	232	10287	5330,122618,113026,51196	PLCB2,PLD4,PLCD3,PLCE1
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.00342899056180983	-5.67548935796655	14	3	0.0129310344827586	232	10287	11001,5740,51302	SLC27A2,PTGIS,CYP39A1
R-HSA-1483249	Inositol phosphate metabolism	0.00396333562307674	-5.530669279216	47	5	0.021551724137931	232	10287	51196,51477,5330,122618,113026	PLCE1,ISYNA1,PLCB2,PLD4,PLCD3
R-HSA-5576892	Phase 0 - rapid depolarisation	0.00396333562307674	-5.530669279216	47	5	0.021551724137931	232	10287	816,6327,6329,775,6326	CAMK2B,SCN2B,SCN4A,CACNA1C,SCN2A
R-HSA-445095	Interaction between L1 and Ankyrins	0.00435793118949473	-5.43575783205322	30	4	0.0172413793103448	232	10287	288,6326,6327,6329	ANK3,SCN2A,SCN2B,SCN4A
R-HSA-5576891	Cardiac conduction	0.00481501117377866	-5.33601691311612	142	9	0.0387931034482759	232	10287	482,775,6326,89822,816,6546,6327,6329,60598	ATP1B2,CACNA1C,SCN2A,KCNK17,CAMK2B,SLC8A1,SCN2B,SCN4A,KCNK15
R-HSA-3000471	Scavenging by Class B Receptors	0.00484206272097249	-5.33041446702425	5	2	0.00862068965517241	232	10287	338,948	APOB,CD36
R-HSA-5686938	Regulation of TLR by endogenous ligand	0.00510278789111753	-5.27796824329082	16	3	0.0129310344827586	232	10287	948,929,338	CD36,CD14,APOB
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.00609421773769722	-5.10041486920834	17	3	0.0129310344827586	232	10287	816,2891,2905	CAMK2B,GRIA2,GRIN2C
R-HSA-390522	Striated Muscle Contraction	0.00687495725801562	-4.97986985246474	34	4	0.0172413793103448	232	10287	4634,7140,4632,7136	MYL3,TNNT3,MYL1,TNNI2
R-HSA-8851907	MET activates PI3K/AKT signaling	0.00715540570899545	-4.93988716471678	6	2	0.00862068965517241	232	10287	2549,5295	GAB1,PIK3R1
R-HSA-418457	cGMP effects	0.00719278379094421	-4.93467700680751	18	3	0.0129310344827586	232	10287	5136,8654,5593	PDE1A,PDE5A,PRKG2
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	0.00929018534512754	-4.67879677531908	37	4	0.0172413793103448	232	10287	10417,157869,9719,7057	SPON2,SBSPON,ADAMTSL2,THBS1
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	0.00986931412736596	-4.61832491859308	7	2	0.00862068965517241	232	10287	54,5167	ACP5,ENPP1
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	0.0104077154344238	-4.56520787918877	59	5	0.021551724137931	232	10287	157869,9719,10417,143662,7057	SBSPON,ADAMTSL2,SPON2,MUC15,THBS1
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	0.0111727792419246	-4.49427488378589	39	4	0.0172413793103448	232	10287	7057,10417,9719,157869	THBS1,SPON2,ADAMTSL2,SBSPON
R-HSA-112316	Neuronal System	0.0126271841464479	-4.37190331708494	349	15	0.0646551724137931	232	10287	83988,3739,3764,7881,89822,2891,816,2036,2788,3787,2905,107,5330,127833,9256	NCALD,KCNA4,KCNJ8,KCNAB1,KCNK17,GRIA2,CAMK2B,EPB41L1,GNG7,KCNS1,GRIN2C,ADCY1,PLCB2,SYT2,TSPOAP1
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.0127057911016894	-4.36569739719146	22	3	0.0129310344827586	232	10287	2149,2147,2162	F2R,F2,F13A1
R-HSA-77111	Synthesis of Ketone Bodies	0.0129647009171771	-4.34552492873603	8	2	0.00862068965517241	232	10287	54511,3158	HMGCLL1,HMGCS2
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.01328498443698	-4.32112087124414	41	4	0.0172413793103448	232	10287	2905,816,2891,107	GRIN2C,CAMK2B,GRIA2,ADCY1
R-HSA-5365859	RA biosynthesis pathway	0.0143727212140153	-4.24242322910743	23	3	0.0129310344827586	232	10287	126,216,127	ADH1C,ALDH1A1,ADH4
R-HSA-5654695	PI-3K cascade:FGFR2	0.0143727212140153	-4.24242322910743	23	3	0.0129310344827586	232	10287	5295,2549,2252	PIK3R1,GAB1,FGF7
R-HSA-5173105	O-linked glycosylation	0.014530430894124	-4.23151014635969	114	7	0.0301724137931034	232	10287	143662,7057,9719,157869,374907,10417,256435	MUC15,THBS1,ADAMTSL2,SBSPON,B3GNT8,SPON2,ST6GALNAC3
R-HSA-5362517	Signaling by Retinoic Acid	0.015635638800465	-4.15820243182573	43	4	0.0172413793103448	232	10287	126,216,127,5166	ADH1C,ALDH1A1,ADH4,PDK4
R-HSA-109582	Hemostasis	0.0156662013959387	-4.15624966451276	632	23	0.0991379310344828	232	10287	8654,482,5593,5023,2162,4778,113220,2147,2788,4352,948,2625,2149,6382,9127,7057,338,3798,285,5136,5295,23539,6546	PDE5A,ATP1B2,PRKG2,P2RX1,F13A1,NFE2,KIF12,F2,GNG7,MPL,CD36,GATA3,F2R,SDC1,P2RX6,THBS1,APOB,KIF5A,ANGPT2,PDE1A,PIK3R1,SLC16A8,SLC8A1
R-HSA-556833	Metabolism of lipids and lipoproteins	0.0159092385463834	-4.14085529784167	813	28	0.120689655172414	232	10287	415,162466,5740,147323,129807,29881,55825,122618,948,51302,1149,54511,5649,788,33,7069,3158,11001,151742,1490,51171,338,5244,165679,1757,5295,117245,375775	ARSE,PHOSPHO1,PTGIS,STARD6,NEU4,NPC1L1,PECR,PLD4,CD36,CYP39A1,CIDEA,HMGCLL1,RELN,SLC25A20,ACADL,THRSP,HMGCS2,SLC27A2,PPM1L,CCN2,HSD17B14,APOB,ABCB4,SPTSSB,SARDH,PIK3R1,PLAAT5,PNPLA7
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.0161576737274503	-4.12536018876061	24	3	0.0129310344827586	232	10287	5593,8654,5136	PRKG2,PDE5A,PDE1A
R-HSA-74182	Ketone body metabolism	0.0164231298203276	-4.1090645828703	9	2	0.00862068965517241	232	10287	54511,3158	HMGCLL1,HMGCS2
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.0174837917223869	-4.04648101452132	146	8	0.0344827586206897	232	10287	2905,2788,107,5330,83988,2891,816,2036	GRIN2C,GNG7,ADCY1,PLCB2,NCALD,GRIA2,CAMK2B,EPB41L1
R-HSA-983712	Ion channel transport	0.0200315965964063	-3.91044442222617	209	10	0.0431034482758621	232	10287	41,816,55283,1188,121601,22802,482,8001,10396,79895	ASIC1,CAMK2B,MCOLN3,CLCNKB,ANO4,CLCA4,ATP1B2,GLRA3,ATP8A1,ATP8B4
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	0.0202267959341597	-3.90074702224639	10	2	0.00862068965517241	232	10287	2549,5295	GAB1,PIK3R1
R-HSA-168799	Neurotoxicity of clostridium toxins	0.0202267959341597	-3.90074702224639	10	2	0.00862068965517241	232	10287	127833,9899	SYT2,SV2B
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.0226040424651266	-3.78962651856091	48	4	0.0172413793103448	232	10287	2042,2044,2051,2049	EPHA3,EPHA5,EPHB6,EPHB3
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.0243585068142509	-3.71487413464268	11	2	0.00862068965517241	232	10287	929,948	CD14,CD36
R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.0243585068142509	-3.71487413464268	11	2	0.00862068965517241	232	10287	929,948	CD14,CD36
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.0243585068142509	-3.71487413464268	11	2	0.00862068965517241	232	10287	788,7069	SLC25A20,THRSP
R-HSA-5655291	Signaling by FGFR4 in disease	0.0243585068142509	-3.71487413464268	11	2	0.00862068965517241	232	10287	2549,5295	GAB1,PIK3R1
R-HSA-1296071	Potassium Channels	0.0253923210666908	-3.67330847087464	100	6	0.0258620689655172	232	10287	2788,3787,3764,7881,3739,89822	GNG7,KCNS1,KCNJ8,KCNAB1,KCNA4,KCNK17
R-HSA-211979	Eicosanoids	0.0288016640987352	-3.54732211230342	12	2	0.00862068965517241	232	10287	5740,66002	PTGIS,CYP4F12
R-HSA-425407	SLC-mediated transmembrane transport	0.0293456756863827	-3.52861007963179	287	12	0.0517241379310345	232	10287	6508,10991,6546,5172,23539,53919,55867,30061,2030,55089,25769,6563	SLC4A3,SLC38A3,SLC8A1,SLC26A4,SLC16A8,SLCO1C1,SLC22A11,SLC40A1,SLC29A1,SLC38A4,SLC24A2,SLC14A1
R-HSA-445717	Aquaporin-mediated transport	0.0293487344019738	-3.52850585452452	52	4	0.0172413793103448	232	10287	364,2788,360,107	AQP7,GNG7,AQP3,ADCY1
R-HSA-5654696	Downstream signaling of activated FGFR2	0.0293738405179714	-3.52765077902548	30	3	0.0129310344827586	232	10287	2252,5295,2549	FGF7,PIK3R1,GAB1
R-HSA-418360	Platelet calcium homeostasis	0.0319942760954939	-3.44219826419773	31	3	0.0129310344827586	232	10287	6546,9127,5023	SLC8A1,P2RX6,P2RX1
R-HSA-5339562	Uptake and actions of bacterial toxins	0.0319942760954939	-3.44219826419773	31	3	0.0129310344827586	232	10287	5608,9899,127833	MAP2K6,SV2B,SYT2
R-HSA-2029481	FCGR activation	0.0335402456429995	-3.39500919873198	13	2	0.00862068965517241	232	10287	2214,2209	FCGR3A,FCGR1A
R-HSA-425561	Sodium/Calcium exchangers	0.0335402456429995	-3.39500919873198	13	2	0.00862068965517241	232	10287	6546,25769	SLC8A1,SLC24A2
R-HSA-432047	Passive transport by Aquaporins	0.0335402456429995	-3.39500919873198	13	2	0.00862068965517241	232	10287	364,360	AQP7,AQP3
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.0338739748286795	-3.38510826360023	107	6	0.0258620689655172	232	10287	6508,10991,55089,5172,6546,25769	SLC4A3,SLC38A3,SLC38A4,SLC26A4,SLC8A1,SLC24A2
R-HSA-202733	Cell surface interactions at the vascular wall	0.034198642282891	-3.37556933503229	136	7	0.0301724137931034	232	10287	2147,482,285,338,23539,5295,6382	F2,ATP1B2,ANGPT2,APOB,SLC16A8,PIK3R1,SDC1
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.0347328860728563	-3.36006831539499	32	3	0.0129310344827586	232	10287	2149,2147,2788	F2R,F2,GNG7
R-HSA-399719	Trafficking of AMPA receptors	0.0347328860728563	-3.36006831539499	32	3	0.0129310344827586	232	10287	2891,816,2036	GRIA2,CAMK2B,EPB41L1
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.0347328860728563	-3.36006831539499	32	3	0.0129310344827586	232	10287	5330,2788,83988	PLCB2,GNG7,NCALD
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.0347328860728563	-3.36006831539499	32	3	0.0129310344827586	232	10287	816,2891,2036	CAMK2B,GRIA2,EPB41L1
R-HSA-4085001	Sialic acid metabolism	0.0375888383440604	-3.28104812520731	33	3	0.0129310344827586	232	10287	129807,338596,256435	NEU4,ST8SIA6,ST6GALNAC3
R-HSA-192105	Synthesis of bile acids and bile salts	0.0405611494164329	-3.20494458143129	34	3	0.0129310344827586	232	10287	5740,11001,51302	PTGIS,SLC27A2,CYP39A1
R-HSA-3928663	EPHA-mediated growth cone collapse	0.0405611494164329	-3.20494458143129	34	3	0.0129310344827586	232	10287	2042,2044,10398	EPHA3,EPHA5,MYL9
R-HSA-936837	Ion transport by P-type ATPases	0.0414819105669312	-3.18249783672659	58	4	0.0172413793103448	232	10287	79895,482,816,10396	ATP8B4,ATP1B2,CAMK2B,ATP8A1
R-HSA-422475	Axon guidance	0.0416263391796321	-3.1790221587154	549	19	0.0818965517241379	232	10287	4684,2252,288,5295,6326,55740,54209,10398,2042,2044,816,2905,6327,6329,2549,3815,775,2051,2049	NCAM1,FGF7,ANK3,PIK3R1,SCN2A,ENAH,TREM2,MYL9,EPHA3,EPHA5,CAMK2B,GRIN2C,SCN2B,SCN4A,GAB1,KIT,CACNA1C,EPHB6,EPHB3
R-HSA-111885	Opioid Signalling	0.0428083163916461	-3.15102288705375	85	5	0.021551724137931	232	10287	5136,84152,2788,5330,107	PDE1A,PPP1R1B,GNG7,PLCB2,ADCY1
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.044598990121902	-3.11004406321916	2	1	0.00431034482758621	232	10287	8908	GYG2
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.044598990121902	-3.11004406321916	2	1	0.00431034482758621	232	10287	364	AQP7
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.044598990121902	-3.11004406321916	2	1	0.00431034482758621	232	10287	89822	KCNK17
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.044598990121902	-3.11004406321916	2	1	0.00431034482758621	232	10287	5740	PTGIS
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.044598990121902	-3.11004406321916	2	1	0.00431034482758621	232	10287	929	CD14
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.044598990121902	-3.11004406321916	2	1	0.00431034482758621	232	10287	8908	GYG2
R-HSA-445355	Smooth Muscle Contraction	0.046850216770654	-3.06079964340011	36	3	0.0129310344827586	232	10287	4638,25802,10398	MYLK,LMOD1,MYL9
R-HSA-418555	G alpha (s) signalling events	0.0472098825298935	-3.05315203267331	146	7	0.0301724137931034	232	10287	27115,10268,107,8622,2788,5136,5745	PDE7B,RAMP3,ADCY1,PDE8B,GNG7,PDE1A,PTH1R
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.0493765963818554	-3.0082787244991	16	2	0.00862068965517241	232	10287	5295,2549	PIK3R1,GAB1
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.0493765963818554	-3.0082787244991	16	2	0.00862068965517241	232	10287	2549,5295	GAB1,PIK3R1
R-HSA-1963642	PI3K events in ERBB2 signaling	0.0493765963818554	-3.0082787244991	16	2	0.00862068965517241	232	10287	2549,5295	GAB1,PIK3R1
R-HSA-438064	Post NMDA receptor activation events	0.050164337190885	-2.99245091927263	37	3	0.0129310344827586	232	10287	107,816,2905	ADCY1,CAMK2B,GRIN2C
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.0535895626330278	-2.92640095686289	38	3	0.0129310344827586	232	10287	6648,50507,2878	SOD2,NOX4,GPX3
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	0.0551475802029469	-2.89774241089171	17	2	0.00862068965517241	232	10287	5169,5167	ENPP3,ENPP1
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.0551475802029469	-2.89774241089171	17	2	0.00862068965517241	232	10287	9127,5023	P2RX6,P2RX1
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	0.0551475802029469	-2.89774241089171	17	2	0.00862068965517241	232	10287	2905,816	GRIN2C,CAMK2B
R-HSA-70221	Glycogen breakdown (glycogenolysis)	0.0551475802029469	-2.89774241089171	17	2	0.00862068965517241	232	10287	5260,8908	PHKG1,GYG2
R-HSA-373080	Class B/2 (Secretin family receptors)	0.0566963053545564	-2.87004623166682	92	5	0.021551724137931	232	10287	2788,5745,3549,8325,10268	GNG7,PTH1R,IHH,FZD8,RAMP3
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	0.0571242945812836	-2.86252577853052	39	3	0.0129310344827586	232	10287	2149,2162,2147	F2R,F13A1,F2
R-HSA-112315	Transmission across Chemical Synapses	0.0572340196459388	-2.86060680833463	217	9	0.0387931034482759	232	10287	2788,2905,107,5330,9256,83988,2891,816,2036	GNG7,GRIN2C,ADCY1,PLCB2,TSPOAP1,NCALD,GRIA2,CAMK2B,EPB41L1
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.0587240615207459	-2.83490572948021	65	4	0.0172413793103448	232	10287	3815,2252,2549,5295	KIT,FGF7,GAB1,PIK3R1
R-HSA-210993	Tie2 Signaling	0.0611419297539811	-2.79455740014576	18	2	0.00862068965517241	232	10287	5295,285	PIK3R1,ANGPT2
R-HSA-5635838	Activation of SMO	0.0611419297539811	-2.79455740014576	18	2	0.00862068965517241	232	10287	2619,3549	GAS1,IHH
R-HSA-5654710	PI-3K cascade:FGFR3	0.0611419297539811	-2.79455740014576	18	2	0.00862068965517241	232	10287	2549,5295	GAB1,PIK3R1
R-HSA-375276	Peptide ligand-binding receptors	0.0627291362604325	-2.76892924613084	188	8	0.0344827586206897	232	10287	2149,4987,2147,886,2359,7504,6755,51554	F2R,OPRL1,F2,CCKAR,FPR3,XK,SSTR5,ACKR4
R-HSA-2682334	EPH-Ephrin signaling	0.0633548490494095	-2.75900383134938	95	5	0.021551724137931	232	10287	10398,2051,2042,2044,2049	MYL9,EPHB6,EPHA3,EPHA5,EPHB3
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.066150087282498	-2.71582906895873	3	1	0.00431034482758621	232	10287	33	ACADL
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.066150087282498	-2.71582906895873	3	1	0.00431034482758621	232	10287	2735	GLI1
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.066150087282498	-2.71582906895873	3	1	0.00431034482758621	232	10287	127833	SYT2
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.066150087282498	-2.71582906895873	3	1	0.00431034482758621	232	10287	9899	SV2B
R-HSA-265473	Trafficking of dietary sterols	0.066150087282498	-2.71582906895873	3	1	0.00431034482758621	232	10287	29881	NPC1L1
R-HSA-5658034	HHAT G278V abrogates palmitoylation of Hh-Np	0.066150087282498	-2.71582906895873	3	1	0.00431034482758621	232	10287	3549	IHH
R-HSA-5357572	Lysosomal glycogen catabolism	0.066150087282498	-2.71582906895873	3	1	0.00431034482758621	232	10287	8908	GYG2
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.066150087282498	-2.71582906895873	3	1	0.00431034482758621	232	10287	57134	MAN1C1
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.06734673205651	-2.69790089910685	19	2	0.00862068965517241	232	10287	2905,816	GRIN2C,CAMK2B
R-HSA-3928664	Ephrin signaling	0.06734673205651	-2.69790089910685	19	2	0.00862068965517241	232	10287	2049,2051	EPHB3,EPHB6
R-HSA-5576886	Phase 4 - resting membrane potential	0.06734673205651	-2.69790089910685	19	2	0.00862068965517241	232	10287	60598,89822	KCNK15,KCNK17
R-HSA-1474244	Extracellular matrix organization	0.0718474641095452	-2.63320996131037	296	11	0.0474137931034483	232	10287	4684,827,81578,7057,6382,8200,54829,7143,50859,11131,4237	NCAM1,CAPN6,COL21A1,THBS1,SDC1,GDF5,ASPN,TNR,SPOCK3,CAPN11,MFAP2
R-HSA-5655253	Signaling by FGFR2 in disease	0.0723230650017341	-2.62661218268822	43	3	0.0129310344827586	232	10287	2252,2549,5295	FGF7,GAB1,PIK3R1
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.0723230650017341	-2.62661218268822	43	3	0.0129310344827586	232	10287	360,2788,107	AQP3,GNG7,ADCY1
R-HSA-194068	Bile acid and bile salt metabolism	0.0723230650017341	-2.62661218268822	43	3	0.0129310344827586	232	10287	51302,11001,5740	CYP39A1,SLC27A2,PTGIS
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.0737495385389778	-2.60708054088039	20	2	0.00862068965517241	232	10287	2549,5295	GAB1,PIK3R1
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.0737495385389778	-2.60708054088039	20	2	0.00862068965517241	232	10287	2549,5295	GAB1,PIK3R1
R-HSA-418217	G beta:gamma signalling through PLC beta	0.0737495385389778	-2.60708054088039	20	2	0.00862068965517241	232	10287	5330,2788	PLCB2,GNG7
R-HSA-3000170	Syndecan interactions	0.0737495385389778	-2.60708054088039	20	2	0.00862068965517241	232	10287	7057,6382	THBS1,SDC1
R-HSA-5654720	PI-3K cascade:FGFR4	0.0737495385389778	-2.60708054088039	20	2	0.00862068965517241	232	10287	5295,2549	PIK3R1,GAB1
R-HSA-1643713	Signaling by EGFR in Cancer	0.0737495385389778	-2.60708054088039	20	2	0.00862068965517241	232	10287	2549,5295	GAB1,PIK3R1
R-HSA-1296072	Voltage gated Potassium channels	0.0763782019058898	-2.57205793888777	44	3	0.0129310344827586	232	10287	7881,3739,3787	KCNAB1,KCNA4,KCNS1
R-HSA-373760	L1CAM interactions	0.077934899309095	-2.55188142502765	101	5	0.021551724137931	232	10287	6327,6329,288,4684,6326	SCN2B,SCN4A,ANK3,NCAM1,SCN2A
R-HSA-5654689	PI-3K cascade:FGFR1	0.0803383507939928	-2.5215081780935	21	2	0.00862068965517241	232	10287	5295,2549	PIK3R1,GAB1
R-HSA-500657	Presynaptic function of Kainate receptors	0.0803383507939928	-2.5215081780935	21	2	0.00862068965517241	232	10287	2788,5330	GNG7,PLCB2
R-HSA-162582	Signal Transduction	0.0838445567840237	-2.47879070893188	2548	67	0.288793103448276	232	10287	343637,340419,7057,6382,64399,8549,8325,80310,5136,8622,338,1124,64388,84152,2549,27334,22943,216,55553,80004,80835,5330,6755,2359,80319,4987,5593,10811,54763,7504,5745,10398,816,2149,57449,9241,126,3714,6017,2735,3798,2619,56656,2670,10268,886,5166,144165,84033,107,127,3549,27115,5295,4684,2252,84894,115703,3249,3815,57569,4638,51554,2788,401541,2147,2905	RSPO4,RSPO2,THBS1,SDC1,HHIP,LGR5,FZD8,PDGFD,PDE1A,PDE8B,APOB,CHN2,GREM2,PPP1R1B,GAB1,P2RY10,DKK1,ALDH1A1,SOX6,ESRP2,TAS1R1,PLCB2,SSTR5,FPR3,CXXC4,OPRL1,PRKG2,NOXA1,ROPN1,XK,PTH1R,MYL9,CAMK2B,F2R,PLEKHG5,NOG,ADH1C,JAG2,RLBP1,GLI1,KIF5A,GAS1,OR2S2,GFAP,RAMP3,CCKAR,PDK4,PRICKLE1,OBSCN,ADCY1,ADH4,IHH,PDE7B,PIK3R1,NCAM1,FGF7,LINGO1,ARHGAP33,HPN,KIT,ARHGAP20,MYLK,ACKR4,GNG7,CENPP,F2,GRIN2C
R-HSA-2672351	Stimuli-sensing channels	0.0858472587460627	-2.45518562288738	104	5	0.021551724137931	232	10287	121601,1188,22802,41,55283	ANO4,CLCNKB,CLCA4,ASIC1,MCOLN3
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	0.0871016067614736	-2.44067994797496	22	2	0.00862068965517241	232	10287	2549,5295	GAB1,PIK3R1
R-HSA-5655332	Signaling by FGFR3 in disease	0.0871016067614736	-2.44067994797496	22	2	0.00862068965517241	232	10287	2549,5295	GAB1,PIK3R1
R-HSA-399710	Activation of AMPA receptors	0.087217102039685	-2.43935484298875	4	1	0.00431034482758621	232	10287	2891	GRIA2
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.087217102039685	-2.43935484298875	4	1	0.00431034482758621	232	10287	9899	SV2B
R-HSA-3000497	Scavenging by Class H Receptors	0.087217102039685	-2.43935484298875	4	1	0.00431034482758621	232	10287	338	APOB
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.087217102039685	-2.43935484298875	4	1	0.00431034482758621	232	10287	8908	GYG2
R-HSA-8866906	TFAP2 (AP-2) family regulates transcription of other transcription factors	0.087217102039685	-2.43935484298875	4	1	0.00431034482758621	232	10287	10370	CITED2
R-HSA-1296025	ATP sensitive Potassium channels	0.087217102039685	-2.43935484298875	4	1	0.00431034482758621	232	10287	3764	KCNJ8
R-HSA-500792	GPCR ligand binding	0.0879745260240604	-2.4307079834098	453	15	0.0646551724137931	232	10287	80835,2149,4987,2147,2788,886,5745,27334,3549,2359,7504,10268,6755,8325,51554	TAS1R1,F2R,OPRL1,F2,GNG7,CCKAR,PTH1R,P2RY10,IHH,FPR3,XK,RAMP3,SSTR5,FZD8,ACKR4
R-HSA-5654738	Signaling by FGFR2	0.0889648016029143	-2.41951447508355	75	4	0.0172413793103448	232	10287	80004,2252,2549,5295	ESRP2,FGF7,GAB1,PIK3R1
R-HSA-112043	PLC beta mediated events	0.089123785379806	-2.41772902861761	47	3	0.0129310344827586	232	10287	5136,107,5330	PDE1A,ADCY1,PLCB2
R-HSA-112040	G-protein mediated events	0.0935584349081913	-2.36916906562122	48	3	0.0129310344827586	232	10287	107,5330,5136	ADCY1,PLCB2,PDE1A
R-HSA-5627123	RHO GTPases activate PAKs	0.0940281672916714	-2.36416088955978	23	2	0.00862068965517241	232	10287	10398,4638	MYL9,MYLK
R-HSA-8855121	VLDL interactions	0.0940281672916714	-2.36416088955978	23	2	0.00862068965517241	232	10287	5649,338	RELN,APOB
R-HSA-196854	Metabolism of vitamins and cofactors	0.0987602148083182	-2.31506043945367	174	7	0.0301724137931034	232	10287	5740,338,5169,54,6382,5167,10840	PTGIS,APOB,ENPP3,ACP5,SDC1,ENPP1,ALDH1L1
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.101107303069365	-2.29157291946802	24	2	0.00862068965517241	232	10287	929,948	CD14,CD36
R-HSA-5260271	Diseases of Immune System	0.101107303069365	-2.29157291946802	24	2	0.00862068965517241	232	10287	948,929	CD36,CD14
R-HSA-201451	Signaling by BMP	0.101107303069365	-2.29157291946802	24	2	0.00862068965517241	232	10287	9241,64388	NOG,GREM2
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.101107303069365	-2.29157291946802	24	2	0.00862068965517241	232	10287	5740,11001	PTGIS,SLC27A2
R-HSA-6785807	Interleukin-4 and 13 signaling	0.105872819471518	-2.24551672153234	111	5	0.021551724137931	232	10287	5295,2625,948,6097,2162	PIK3R1,GATA3,CD36,RORC,F13A1
R-HSA-397795	G-protein beta:gamma signalling	0.107389035015927	-2.23129719694318	51	3	0.0129310344827586	232	10287	5295,5330,2788	PIK3R1,PLCB2,GNG7
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	0.107810861868684	-2.22737686613337	5	1	0.00431034482758621	232	10287	9899	SV2B
R-HSA-2161541	Abacavir metabolism	0.107810861868684	-2.22737686613337	5	1	0.00431034482758621	232	10287	5105	PCK1
R-HSA-167826	The fatty acid cycling model	0.107810861868684	-2.22737686613337	5	1	0.00431034482758621	232	10287	7351	UCP2
R-HSA-389599	Alpha-oxidation of phytanate	0.107810861868684	-2.22737686613337	5	1	0.00431034482758621	232	10287	11001	SLC27A2
R-HSA-70350	Fructose catabolism	0.107810861868684	-2.22737686613337	5	1	0.00431034482758621	232	10287	216	ALDH1A1
R-HSA-8865999	MET activates PTPN11	0.107810861868684	-2.22737686613337	5	1	0.00431034482758621	232	10287	2549	GAB1
R-HSA-166187	Mitochondrial Uncoupling Proteins	0.107810861868684	-2.22737686613337	5	1	0.00431034482758621	232	10287	7351	UCP2
R-HSA-167827	The proton buffering model	0.107810861868684	-2.22737686613337	5	1	0.00431034482758621	232	10287	7351	UCP2
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	0.107810861868684	-2.22737686613337	5	1	0.00431034482758621	232	10287	57134	MAN1C1
R-HSA-561048	Organic anion transport	0.107810861868684	-2.22737686613337	5	1	0.00431034482758621	232	10287	55867	SLC22A11
R-HSA-8852405	Signaling by MST1	0.107810861868684	-2.22737686613337	5	1	0.00431034482758621	232	10287	3249	HPN
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	0.107810861868684	-2.22737686613337	5	1	0.00431034482758621	232	10287	33	ACADL
R-HSA-8866423	VLDL biosynthesis	0.107810861868684	-2.22737686613337	5	1	0.00431034482758621	232	10287	338	APOB
R-HSA-8866376	Reelin signalling pathway	0.107810861868684	-2.22737686613337	5	1	0.00431034482758621	232	10287	5649	RELN
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	0.107810861868684	-2.22737686613337	5	1	0.00431034482758621	232	10287	9899	SV2B
R-HSA-977068	Termination of O-glycan biosynthesis	0.108328681944638	-2.22258532213793	25	2	0.00862068965517241	232	10287	143662,256435	MUC15,ST6GALNAC3
R-HSA-5654708	Downstream signaling of activated FGFR3	0.108328681944638	-2.22258532213793	25	2	0.00862068965517241	232	10287	5295,2549	PIK3R1,GAB1
R-HSA-70326	Glucose metabolism	0.110071626062359	-2.20662397907186	81	4	0.0172413793103448	232	10287	5260,5224,8908,5105	PHKG1,PGAM2,GYG2,PCK1
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.115682356595788	-2.15690714910052	26	2	0.00862068965517241	232	10287	4958,6382	OMD,SDC1
R-HSA-210991	Basigin interactions	0.115682356595788	-2.15690714910052	26	2	0.00862068965517241	232	10287	482,23539	ATP1B2,SLC16A8
R-HSA-5654716	Downstream signaling of activated FGFR4	0.123158752544032	-2.09428108471997	27	2	0.00862068965517241	232	10287	2549,5295	GAB1,PIK3R1
R-HSA-6806942	MET Receptor Activation	0.127941953100572	-2.05617860932263	6	1	0.00431034482758621	232	10287	3249	HPN
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	0.127941953100572	-2.05617860932263	6	1	0.00431034482758621	232	10287	80319	CXXC4
R-HSA-193144	Estrogen biosynthesis	0.127941953100572	-2.05617860932263	6	1	0.00431034482758621	232	10287	51171	HSD17B14
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.127941953100572	-2.05617860932263	6	1	0.00431034482758621	232	10287	22943	DKK1
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.127941953100572	-2.05617860932263	6	1	0.00431034482758621	232	10287	33	ACADL
R-HSA-111957	Cam-PDE 1 activation	0.127941953100572	-2.05617860932263	6	1	0.00431034482758621	232	10287	5136	PDE1A
R-HSA-5690714	CD22 mediated BCR regulation	0.127941953100572	-2.05617860932263	6	1	0.00431034482758621	232	10287	974	CD79B
R-HSA-6798163	Choline catabolism	0.127941953100572	-2.05617860932263	6	1	0.00431034482758621	232	10287	1757	SARDH
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	0.127941953100572	-2.05617860932263	6	1	0.00431034482758621	232	10287	6017	RLBP1
R-HSA-3000484	Scavenging by Class F Receptors	0.127941953100572	-2.05617860932263	6	1	0.00431034482758621	232	10287	338	APOB
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.1292046945487	-2.0463573527775	86	4	0.0172413793103448	232	10287	122618,5295,2209,2214	PLD4,PIK3R1,FCGR1A,FCGR3A
R-HSA-5632684	Hedgehog 'on' state	0.1292046945487	-2.0463573527775	86	4	0.0172413793103448	232	10287	2619,3549,2735,64399	GAS1,IHH,GLI1,HHIP
R-HSA-70268	Pyruvate metabolism	0.130748656530345	-2.03447845119241	28	2	0.00862068965517241	232	10287	5166,23539	PDK4,SLC16A8
R-HSA-211976	Endogenous sterols	0.130748656530345	-2.03447845119241	28	2	0.00862068965517241	232	10287	5740,51302	PTGIS,CYP39A1
R-HSA-111997	CaM pathway	0.130748656530345	-2.03447845119241	28	2	0.00862068965517241	232	10287	5136,107	PDE1A,ADCY1
R-HSA-111933	Calmodulin induced events	0.130748656530345	-2.03447845119241	28	2	0.00862068965517241	232	10287	5136,107	PDE1A,ADCY1
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.130748656530345	-2.03447845119241	28	2	0.00862068965517241	232	10287	775,2788	CACNA1C,GNG7
R-HSA-5578775	Ion homeostasis	0.132054267884962	-2.02454232054196	56	3	0.0129310344827586	232	10287	482,816,6546	ATP1B2,CAMK2B,SLC8A1
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	0.133188482573062	-2.01598999178355	87	4	0.0172413793103448	232	10287	5295,2549,3815,2252	PIK3R1,GAB1,KIT,FGF7
R-HSA-3000178	ECM proteoglycans	0.137207837989246	-1.98625843712061	57	3	0.0129310344827586	232	10287	4684,7143,54829	NCAM1,TNR,ASPN
R-HSA-416482	G alpha (12/13) signalling events	0.137222319025676	-1.98615290180626	88	4	0.0172413793103448	232	10287	2788,57449,84033,5295	GNG7,PLEKHG5,OBSCN,PIK3R1
R-HSA-390918	Peroxisomal lipid metabolism	0.138443205189608	-1.97729510828993	29	2	0.00862068965517241	232	10287	11001,55825	SLC27A2,PECR
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.138443205189608	-1.97729510828993	29	2	0.00862068965517241	232	10287	2905,816	GRIN2C,CAMK2B
R-HSA-195721	Signaling by Wnt	0.138489114797209	-1.97696354996533	336	11	0.0474137931034483	232	10287	80319,2788,22943,8325,5330,144165,8549,340419,343637,55553,5593	CXXC4,GNG7,DKK1,FZD8,PLCB2,PRICKLE1,LGR5,RSPO2,RSPO4,SOX6,PRKG2
R-HSA-190236	Signaling by FGFR	0.141305166513733	-1.95683342581479	89	4	0.0172413793103448	232	10287	5295,2549,80004,2252	PIK3R1,GAB1,ESRP2,FGF7
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.141492680188174	-1.9555072933558	122	5	0.021551724137931	232	10287	5169,5740,10840,5167,54	ENPP3,PTGIS,ALDH1L1,ENPP1,ACP5
R-HSA-6794361	Interactions of neurexins and neuroligins at synapses	0.142429252211999	-1.94890987826357	58	3	0.0129310344827586	232	10287	2905,2036,127833	GRIN2C,EPB41L1,SYT2
R-HSA-416476	G alpha (q) signalling events	0.143581400961482	-1.94085315052326	192	7	0.0301724137931034	232	10287	5330,5295,2149,2147,2788,27334,886	PLCB2,PIK3R1,F2R,F2,GNG7,P2RY10,CCKAR
R-HSA-428157	Sphingolipid metabolism	0.145435973125634	-1.9280193364663	90	4	0.0172413793103448	232	10287	415,151742,129807,165679	ARSE,PPM1L,NEU4,SPTSSB
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.145435973125634	-1.9280193364663	90	4	0.0172413793103448	232	10287	3815,2252,5295,2549	KIT,FGF7,PIK3R1,GAB1
R-HSA-111996	Ca-dependent events	0.146233874092596	-1.92254806156427	30	2	0.00862068965517241	232	10287	107,5136	ADCY1,PDE1A
R-HSA-5652084	Fructose metabolism	0.14762072626359	-1.91310895483395	7	1	0.00431034482758621	232	10287	216	ALDH1A1
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.14762072626359	-1.91310895483395	7	1	0.00431034482758621	232	10287	3714	JAG2
R-HSA-433692	Proton-coupled monocarboxylate transport	0.14762072626359	-1.91310895483395	7	1	0.00431034482758621	232	10287	23539	SLC16A8
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	0.14762072626359	-1.91310895483395	7	1	0.00431034482758621	232	10287	4958	OMD
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	0.14762072626359	-1.91310895483395	7	1	0.00431034482758621	232	10287	107	ADCY1
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	0.14762072626359	-1.91310895483395	7	1	0.00431034482758621	232	10287	4958	OMD
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	0.14762072626359	-1.91310895483395	7	1	0.00431034482758621	232	10287	2030	SLC29A1
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.14762072626359	-1.91310895483395	7	1	0.00431034482758621	232	10287	3714	JAG2
R-HSA-3656225	Defective CHST6 causes MCDC1	0.14762072626359	-1.91310895483395	7	1	0.00431034482758621	232	10287	4958	OMD
R-HSA-6814848	Glycerophospholipid catabolism	0.14762072626359	-1.91310895483395	7	1	0.00431034482758621	232	10287	375775	PNPLA7
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	0.154112467059489	-1.87007263753077	31	2	0.00862068965517241	232	10287	2875,374569	GPT,ASPG
R-HSA-1296065	Inwardly rectifying K+ channels	0.154112467059489	-1.87007263753077	31	2	0.00862068965517241	232	10287	3764,2788	KCNJ8,GNG7
R-HSA-352230	Amino acid transport across the plasma membrane	0.154112467059489	-1.87007263753077	31	2	0.00862068965517241	232	10287	10991,55089	SLC38A3,SLC38A4
R-HSA-5654687	Downstream signaling of activated FGFR1	0.154112467059489	-1.87007263753077	31	2	0.00862068965517241	232	10287	5295,2549	PIK3R1,GAB1
R-HSA-2129379	Molecules associated with elastic fibres	0.154112467059489	-1.87007263753077	31	2	0.00862068965517241	232	10287	4237,8200	MFAP2,GDF5
R-HSA-4086398	Ca2+ pathway	0.158476240962881	-1.84215059618864	61	3	0.0129310344827586	232	10287	5330,5593,2788	PLCB2,PRKG2,GNG7
R-HSA-196071	Metabolism of steroid hormones	0.162071105793204	-1.81972011539959	32	2	0.00862068965517241	232	10287	51171,147323	HSD17B14,STARD6
R-HSA-70263	Gluconeogenesis	0.162071105793204	-1.81972011539959	32	2	0.00862068965517241	232	10287	5105,5224	PCK1,PGAM2
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.162417307610078	-1.81758628297947	94	4	0.0172413793103448	232	10287	5295,2549,2252,3815	PIK3R1,GAB1,FGF7,KIT
R-HSA-70921	Histidine catabolism	0.166857301307566	-1.79061631503247	8	1	0.00431034482758621	232	10287	57571	CARNS1
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.166857301307566	-1.79061631503247	8	1	0.00431034482758621	232	10287	3549	IHH
R-HSA-1483148	Synthesis of PG	0.166857301307566	-1.79061631503247	8	1	0.00431034482758621	232	10287	122618	PLD4
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	0.166857301307566	-1.79061631503247	8	1	0.00431034482758621	232	10287	2359	FPR3
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	0.166857301307566	-1.79061631503247	8	1	0.00431034482758621	232	10287	948	CD36
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.166857301307566	-1.79061631503247	8	1	0.00431034482758621	232	10287	4913	NTHL1
R-HSA-73928	Depyrimidination	0.166857301307566	-1.79061631503247	8	1	0.00431034482758621	232	10287	4913	NTHL1
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.166857301307566	-1.79061631503247	8	1	0.00431034482758621	232	10287	5330	PLCB2
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.166857301307566	-1.79061631503247	8	1	0.00431034482758621	232	10287	84894	LINGO1
R-HSA-110329	Cleavage of the damaged pyrimidine	0.166857301307566	-1.79061631503247	8	1	0.00431034482758621	232	10287	4913	NTHL1
R-HSA-400451	Free fatty acids regulate insulin secretion	0.166857301307566	-1.79061631503247	8	1	0.00431034482758621	232	10287	5330	PLCB2
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.169468958343296	-1.77508550555091	63	3	0.0129310344827586	232	10287	129807,338596,256435	NEU4,ST8SIA6,ST6GALNAC3
R-HSA-1226099	Signaling by FGFR in disease	0.169468958343296	-1.77508550555091	63	3	0.0129310344827586	232	10287	2549,5295,2252	GAB1,PIK3R1,FGF7
R-HSA-163359	Glucagon signaling in metabolic regulation	0.170102219827061	-1.77135572953578	33	2	0.00862068965517241	232	10287	107,2788	ADCY1,GNG7
R-HSA-1489509	DAG and IP3 signaling	0.178198536723662	-1.72485697540641	34	2	0.00862068965517241	232	10287	5136,107	PDE1A,ADCY1
R-HSA-913709	O-linked glycosylation of mucins	0.180675018829432	-1.71105533759596	65	3	0.0129310344827586	232	10287	143662,374907,256435	MUC15,B3GNT8,ST6GALNAC3
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.185661572750185	-1.68382976391521	9	1	0.00431034482758621	232	10287	54763	ROPN1
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	0.185661572750185	-1.68382976391521	9	1	0.00431034482758621	232	10287	8325	FZD8
R-HSA-193697	p75NTR regulates axonogenesis	0.185661572750185	-1.68382976391521	9	1	0.00431034482758621	232	10287	84894	LINGO1
R-HSA-166665	Terminal pathway of complement	0.185661572750185	-1.68382976391521	9	1	0.00431034482758621	232	10287	730	C7
R-HSA-110357	Displacement of DNA glycosylase by APEX1	0.185661572750185	-1.68382976391521	9	1	0.00431034482758621	232	10287	4913	NTHL1
R-HSA-2453864	Retinoid cycle disease events	0.185661572750185	-1.68382976391521	9	1	0.00431034482758621	232	10287	6017	RLBP1
R-HSA-2474795	Diseases associated with visual transduction	0.185661572750185	-1.68382976391521	9	1	0.00431034482758621	232	10287	6017	RLBP1
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.185661572750185	-1.68382976391521	9	1	0.00431034482758621	232	10287	760	CA2
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	0.185661572750185	-1.68382976391521	9	1	0.00431034482758621	232	10287	2147	F2
R-HSA-4791275	Signaling by WNT in cancer	0.186353072618602	-1.68011216476456	35	2	0.00862068965517241	232	10287	8325,22943	FZD8,DKK1
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.194559122965004	-1.63701918800128	36	2	0.00862068965517241	232	10287	5136,107	PDE1A,ADCY1
R-HSA-167021	PLC-gamma1 signalling	0.194559122965004	-1.63701918800128	36	2	0.00862068965517241	232	10287	5136,107	PDE1A,ADCY1
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.197842688147887	-1.62028306837702	68	3	0.0129310344827586	232	10287	51302,66002,5740	CYP39A1,CYP4F12,PTGIS
R-HSA-5358351	Signaling by Hedgehog	0.201082011360461	-1.60404243742053	138	5	0.021551724137931	232	10287	2735,64399,2619,107,3549	GLI1,HHIP,GAS1,ADCY1,IHH
R-HSA-419037	NCAM1 interactions	0.20281025357981	-1.59548444848499	37	2	0.00862068965517241	232	10287	775,4684	CACNA1C,NCAM1
R-HSA-6806834	Signaling by MET	0.20365154271699	-1.59134486958132	69	3	0.0129310344827586	232	10287	5295,2549,3249	PIK3R1,GAB1,HPN
R-HSA-430116	GP1b-IX-V activation signalling	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	5295	PIK3R1
R-HSA-6811555	PI5P Regulates TP53 Acetylation	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	5608	MAP2K6
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	2147	F2
R-HSA-5663084	Diseases of carbohydrate metabolism	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	8908	GYG2
R-HSA-3229121	Glycogen storage diseases	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	8908	GYG2
R-HSA-419812	Calcitonin-like ligand receptors	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	10268	RAMP3
R-HSA-159740	Gamma-carboxylation of protein precursors	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	2147	F2
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	33	ACADL
R-HSA-2562578	TRIF-mediated programmed cell death	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	929	CD14
R-HSA-2161522	Abacavir transport and metabolism	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	5105	PCK1
R-HSA-425381	Bicarbonate transporters	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	6508	SLC4A3
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	8908	GYG2
R-HSA-427601	Multifunctional anion exchangers	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	5172	SLC26A4
R-HSA-170660	Adenylate cyclase activating pathway	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	107	ADCY1
R-HSA-399997	Acetylcholine regulates insulin secretion	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	5330	PLCB2
R-HSA-8875656	MET receptor recycling	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	2549	GAB1
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	4913	NTHL1
R-HSA-196108	Pregnenolone biosynthesis	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	147323	STARD6
R-HSA-1250342	PI3K events in ERBB4 signaling	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	5295	PIK3R1
R-HSA-190377	FGFR2b ligand binding and activation	0.204043214616681	-1.58942347121579	10	1	0.00431034482758621	232	10287	2252	FGF7
R-HSA-5655302	Signaling by FGFR1 in disease	0.211100291970918	-1.55542194103588	38	2	0.00862068965517241	232	10287	5295,2549	PIK3R1,GAB1
R-HSA-156590	Glutathione conjugation	0.211100291970918	-1.55542194103588	38	2	0.00862068965517241	232	10287	2946,2953	GSTM2,GSTT2
R-HSA-76009	Platelet Aggregation (Plug Formation)	0.211100291970918	-1.55542194103588	38	2	0.00862068965517241	232	10287	2147,4352	F2,MPL
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.212516491670225	-1.54873568576912	253	8	0.0344827586206897	232	10287	5244,948,1490,3158,7069,788,33,54511	ABCB4,CD36,CCN2,HMGCS2,THRSP,SLC25A20,ACADL,HMGCLL1
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.217153361107988	-1.52715144184346	106	4	0.0172413793103448	232	10287	30061,55867,23539,6563	SLC40A1,SLC22A11,SLC16A8,SLC14A1
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.219423318852544	-1.5167524521373	39	2	0.00862068965517241	232	10287	5295,974	PIK3R1,CD79B
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.219423318852544	-1.5167524521373	39	2	0.00862068965517241	232	10287	2147,415	F2,ARSE
R-HSA-194840	Rho GTPase cycle	0.221246152669824	-1.50847938430823	143	5	0.021551724137931	232	10287	57449,57569,115703,1124,84033	PLEKHG5,ARHGAP20,ARHGAP33,CHN2,OBSCN
R-HSA-6794362	Protein-protein interactions at synapses	0.221305072521843	-1.50821311071542	72	3	0.0129310344827586	232	10287	2905,127833,2036	GRIN2C,SYT2,EPB41L1
R-HSA-71288	Creatine metabolism	0.222011685396946	-1.50502526157195	11	1	0.00431034482758621	232	10287	2593	GAMT
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.222011685396946	-1.50502526157195	11	1	0.00431034482758621	232	10287	51477	ISYNA1
R-HSA-1980150	Signaling by NOTCH4	0.222011685396946	-1.50502526157195	11	1	0.00431034482758621	232	10287	3714	JAG2
R-HSA-71182	Phenylalanine and tyrosine catabolism	0.222011685396946	-1.50502526157195	11	1	0.00431034482758621	232	10287	5053	PAH
R-HSA-5625970	RHO GTPases activate KTN1	0.222011685396946	-1.50502526157195	11	1	0.00431034482758621	232	10287	3798	KIF5A
R-HSA-8875555	MET activates RAP1 and RAC1	0.222011685396946	-1.50502526157195	11	1	0.00431034482758621	232	10287	2549	GAB1
R-HSA-1980148	Signaling by NOTCH3	0.222011685396946	-1.50502526157195	11	1	0.00431034482758621	232	10287	3714	JAG2
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	0.222011685396946	-1.50502526157195	11	1	0.00431034482758621	232	10287	2147	F2
R-HSA-1643685	Disease	0.222174607821995	-1.50429168453528	859	23	0.0991379310344828	232	10287	10417,7057,6382,157869,9719,2252,143662,8325,3714,4958,3549,127833,6017,5295,9899,3815,6648,5608,929,22943,948,2549,8908	SPON2,THBS1,SDC1,SBSPON,ADAMTSL2,FGF7,MUC15,FZD8,JAG2,OMD,IHH,SYT2,RLBP1,PIK3R1,SV2B,KIT,SOD2,MAP2K6,CD14,DKK1,CD36,GAB1,GYG2
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	0.227773659997037	-1.4794028624111	40	2	0.00862068965517241	232	10287	2030,53919	SLC29A1,SLCO1C1
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	0.227773659997037	-1.4794028624111	40	2	0.00862068965517241	232	10287	10370,3815	CITED2,KIT
R-HSA-977444	GABA B receptor activation	0.227773659997037	-1.4794028624111	40	2	0.00862068965517241	232	10287	107,2788	ADCY1,GNG7
R-HSA-991365	Activation of GABAB receptors	0.227773659997037	-1.4794028624111	40	2	0.00862068965517241	232	10287	2788,107	GNG7,ADCY1
R-HSA-5654741	Signaling by FGFR3	0.227773659997037	-1.4794028624111	40	2	0.00862068965517241	232	10287	5295,2549	PIK3R1,GAB1
R-HSA-186797	Signaling by PDGF	0.229278120874253	-1.47281951070412	376	11	0.0474137931034483	232	10287	7057,816,3815,2549,107,80310,5295,4684,5136,2252,2905	THBS1,CAMK2B,KIT,GAB1,ADCY1,PDGFD,PIK3R1,NCAM1,PDE1A,FGF7,GRIN2C
R-HSA-5654743	Signaling by FGFR4	0.236145878230008	-1.44330553682575	41	2	0.00862068965517241	232	10287	2549,5295	GAB1,PIK3R1
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	0.239576232791719	-1.42888361302113	12	1	0.00431034482758621	232	10287	83988	NCALD
R-HSA-1475029	Reversible hydration of carbon dioxide	0.239576232791719	-1.42888361302113	12	1	0.00431034482758621	232	10287	760	CA2
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.239576232791719	-1.42888361302113	12	1	0.00431034482758621	232	10287	6382	SDC1
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	0.239576232791719	-1.42888361302113	12	1	0.00431034482758621	232	10287	5593	PRKG2
R-HSA-2022857	Keratan sulfate degradation	0.239576232791719	-1.42888361302113	12	1	0.00431034482758621	232	10287	4958	OMD
R-HSA-451306	Ionotropic activity of Kainate Receptors	0.239576232791719	-1.42888361302113	12	1	0.00431034482758621	232	10287	83988	NCALD
R-HSA-879518	Transport of organic anions	0.239576232791719	-1.42888361302113	12	1	0.00431034482758621	232	10287	53919	SLCO1C1
R-HSA-3656237	Defective EXT2 causes exostoses 2	0.239576232791719	-1.42888361302113	12	1	0.00431034482758621	232	10287	6382	SDC1
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.239576232791719	-1.42888361302113	12	1	0.00431034482758621	232	10287	10370	CITED2
R-HSA-1296346	Tandem pore domain potassium channels	0.239576232791719	-1.42888361302113	12	1	0.00431034482758621	232	10287	89822	KCNK17
R-HSA-417957	P2Y receptors	0.239576232791719	-1.42888361302113	12	1	0.00431034482758621	232	10287	27334	P2RY10
R-HSA-163685	Integration of energy metabolism	0.241300279691869	-1.42171314724752	111	4	0.0172413793103448	232	10287	2788,775,107,5330	GNG7,CACNA1C,ADCY1,PLCB2
R-HSA-1566948	Elastic fibre formation	0.244534765731797	-1.40839778904332	42	2	0.00862068965517241	232	10287	4237,8200	MFAP2,GDF5
R-HSA-983189	Kinesins	0.244534765731797	-1.40839778904332	42	2	0.00862068965517241	232	10287	113220,3798	KIF12,KIF5A
R-HSA-3928662	EPHB-mediated forward signaling	0.244534765731797	-1.40839778904332	42	2	0.00862068965517241	232	10287	2051,2049	EPHB6,EPHB3
R-HSA-3858494	Beta-catenin independent WNT signaling	0.24621067845604	-1.40156769307716	149	5	0.021551724137931	232	10287	5593,8325,5330,144165,2788	PRKG2,FZD8,PLCB2,PRICKLE1,GNG7
R-HSA-1236394	Signaling by ERBB4	0.252935336497656	-1.37462140988832	43	2	0.00862068965517241	232	10287	5295,2670	PIK3R1,GFAP
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.252935336497656	-1.37462140988832	43	2	0.00862068965517241	232	10287	338,948	APOB,CD36
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	0.256745898382994	-1.35966840544034	13	1	0.00431034482758621	232	10287	4137	MAPT
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	0.256745898382994	-1.35966840544034	13	1	0.00431034482758621	232	10287	10811	NOXA1
R-HSA-5210891	Uptake and function of anthrax toxins	0.256745898382994	-1.35966840544034	13	1	0.00431034482758621	232	10287	5608	MAP2K6
R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	0.256745898382994	-1.35966840544034	13	1	0.00431034482758621	232	10287	10370	CITED2
R-HSA-1663150	The activation of arylsulfatases	0.256745898382994	-1.35966840544034	13	1	0.00431034482758621	232	10287	415	ARSE
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.256745898382994	-1.35966840544034	13	1	0.00431034482758621	232	10287	760	CA2
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.256745898382994	-1.35966840544034	13	1	0.00431034482758621	232	10287	760	CA2
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.257435920722511	-1.3569844414101	78	3	0.0129310344827586	232	10287	129807,256435,338596	NEU4,ST6GALNAC3,ST8SIA6
R-HSA-73923	Lipid digestion, mobilization, and transport	0.261041959002954	-1.34307412211692	115	4	0.0172413793103448	232	10287	1149,338,29881,5649	CIDEA,APOB,NPC1L1,RELN
R-HSA-975634	Retinoid metabolism and transport	0.261342819094544	-1.34192225040293	44	2	0.00862068965517241	232	10287	338,6382	APOB,SDC1
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.261342819094544	-1.34192225040293	44	2	0.00862068965517241	232	10287	165679,151742	SPTSSB,PPM1L
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	0.261342819094544	-1.34192225040293	44	2	0.00862068965517241	232	10287	5053,57571	PAH,CARNS1
R-HSA-109704	PI3K Cascade	0.263539848546459	-1.3335506945542	79	3	0.0129310344827586	232	10287	2252,2549,5295	FGF7,GAB1,PIK3R1
R-HSA-422356	Regulation of insulin secretion	0.269661831507249	-1.31058658088631	80	3	0.0129310344827586	232	10287	775,2788,5330	CACNA1C,GNG7,PLCB2
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.269752649575881	-1.31024985255337	45	2	0.00862068965517241	232	10287	7057,6382	THBS1,SDC1
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.273529522246381	-1.29634572054553	14	1	0.00431034482758621	232	10287	6546	SLC8A1
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.273529522246381	-1.29634572054553	14	1	0.00431034482758621	232	10287	5166	PDK4
R-HSA-1483213	Synthesis of PE	0.273529522246381	-1.29634572054553	14	1	0.00431034482758621	232	10287	162466	PHOSPHO1
R-HSA-1660662	Glycosphingolipid metabolism	0.278160464594176	-1.27955712104314	46	2	0.00862068965517241	232	10287	129807,415	NEU4,ARSE
R-HSA-2424491	DAP12 signaling	0.283330077522089	-1.26114270933042	356	10	0.0431034482758621	232	10287	2252,4684,5136,2905,107,2549,5295,3815,54209,816	FGF7,NCAM1,PDE1A,GRIN2C,ADCY1,GAB1,PIK3R1,KIT,TREM2,CAMK2B
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.28993574738519	-1.23809594129055	15	1	0.00431034482758621	232	10287	5740	PTGIS
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.28993574738519	-1.23809594129055	15	1	0.00431034482758621	232	10287	5740	PTGIS
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.28993574738519	-1.23809594129055	15	1	0.00431034482758621	232	10287	3714	JAG2
R-HSA-975577	N-Glycan antennae elongation	0.28993574738519	-1.23809594129055	15	1	0.00431034482758621	232	10287	338596	ST8SIA6
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.28993574738519	-1.23809594129055	15	1	0.00431034482758621	232	10287	107	ADCY1
R-HSA-3322077	Glycogen synthesis	0.28993574738519	-1.23809594129055	15	1	0.00431034482758621	232	10287	8908	GYG2
R-HSA-211935	Fatty acids	0.28993574738519	-1.23809594129055	15	1	0.00431034482758621	232	10287	66002	CYP4F12
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.28993574738519	-1.23809594129055	15	1	0.00431034482758621	232	10287	3714	JAG2
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.28993574738519	-1.23809594129055	15	1	0.00431034482758621	232	10287	22943	DKK1
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.28993574738519	-1.23809594129055	15	1	0.00431034482758621	232	10287	107	ADCY1
R-HSA-201681	TCF dependent signaling in response to WNT	0.290946199146035	-1.23461691156323	238	7	0.0301724137931034	232	10287	55553,343637,340419,8325,8549,22943,80319	SOX6,RSPO4,RSPO2,FZD8,LGR5,DKK1,CXXC4
R-HSA-418597	G alpha (z) signalling events	0.294953558253768	-1.22093736468391	48	2	0.00862068965517241	232	10287	107,2788	ADCY1,GNG7
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.294953558253768	-1.22093736468391	48	2	0.00862068965517241	232	10287	5295,2788	PIK3R1,GNG7
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.29821505445581	-1.20994039349987	443	12	0.0517241379310345	232	10287	2905,2252,2147,886,4684,27334,2788,5295,5330,3815,2149,816	GRIN2C,FGF7,F2,CCKAR,NCAM1,P2RY10,GNG7,PIK3R1,PLCB2,KIT,F2R,CAMK2B
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	0.302834573592095	-1.19456858430641	322	9	0.0387931034482759	232	10287	2149,4987,51554,7504,6755,2359,27334,886,2147	F2R,OPRL1,ACKR4,XK,SSTR5,FPR3,P2RY10,CCKAR,F2
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	0.303331054355503	-1.1929304812813	49	2	0.00862068965517241	232	10287	23539,5166	SLC16A8,PDK4
R-HSA-76002	Platelet activation, signaling and aggregation	0.30444294614499	-1.18927157836992	282	8	0.0344827586206897	232	10287	2788,2147,2162,948,4352,5295,7057,2149	GNG7,F2,F13A1,CD36,MPL,PIK3R1,THBS1,F2R
R-HSA-1433559	Regulation of KIT signaling	0.305973024117327	-1.18425833739509	16	1	0.00431034482758621	232	10287	3815	KIT
R-HSA-163615	PKA activation	0.305973024117327	-1.18425833739509	16	1	0.00431034482758621	232	10287	107	ADCY1
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.305973024117327	-1.18425833739509	16	1	0.00431034482758621	232	10287	929	CD14
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	0.305973024117327	-1.18425833739509	16	1	0.00431034482758621	232	10287	3815	KIT
R-HSA-549132	Organic cation/anion/zwitterion transport	0.305973024117327	-1.18425833739509	16	1	0.00431034482758621	232	10287	55867	SLC22A11
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.305973024117327	-1.18425833739509	16	1	0.00431034482758621	232	10287	27334	P2RY10
R-HSA-1989781	PPARA activates gene expression	0.306451459217712	-1.18269590737887	124	4	0.0172413793103448	232	10287	1490,3158,5244,948	CCN2,HMGCS2,ABCB4,CD36
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.306451459217712	-1.18269590737887	124	4	0.0172413793103448	232	10287	4068,54209,2209,2214	SH2D1A,TREM2,FCGR1A,FCGR3A
R-HSA-1257604	PIP3 activates AKT signaling	0.311556742440715	-1.16617379862533	125	4	0.0172413793103448	232	10287	3815,2252,2549,5295	KIT,FGF7,GAB1,PIK3R1
R-HSA-5654736	Signaling by FGFR1	0.311690957539108	-1.16574310277046	50	2	0.00862068965517241	232	10287	5295,2549	PIK3R1,GAB1
R-HSA-1227986	Signaling by ERBB2	0.320029811525118	-1.13934112651159	51	2	0.00862068965517241	232	10287	2549,5295	GAB1,PIK3R1
R-HSA-5625900	RHO GTPases activate CIT	0.321649614371188	-1.13429248003401	17	1	0.00431034482758621	232	10287	10398	MYL9
R-HSA-5083632	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)	0.321649614371188	-1.13429248003401	17	1	0.00431034482758621	232	10287	143662	MUC15
R-HSA-140534	Ligand-dependent caspase activation	0.321649614371188	-1.13429248003401	17	1	0.00431034482758621	232	10287	929	CD14
R-HSA-164378	PKA activation in glucagon signalling	0.321649614371188	-1.13429248003401	17	1	0.00431034482758621	232	10287	107	ADCY1
R-HSA-5083636	Defective GALNT12 causes colorectal cancer 1 (CRCS1)	0.321649614371188	-1.13429248003401	17	1	0.00431034482758621	232	10287	143662	MUC15
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.321649614371188	-1.13429248003401	17	1	0.00431034482758621	232	10287	929	CD14
R-HSA-2033519	Activated point mutants of FGFR2	0.321649614371188	-1.13429248003401	17	1	0.00431034482758621	232	10287	2252	FGF7
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	0.321649614371188	-1.13429248003401	17	1	0.00431034482758621	232	10287	9256	TSPOAP1
R-HSA-5627117	RHO GTPases Activate ROCKs	0.321649614371188	-1.13429248003401	17	1	0.00431034482758621	232	10287	10398	MYL9
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.321649614371188	-1.13429248003401	17	1	0.00431034482758621	232	10287	2891	GRIA2
R-HSA-5083625	Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)	0.321649614371188	-1.13429248003401	17	1	0.00431034482758621	232	10287	143662	MUC15
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.321649614371188	-1.13429248003401	17	1	0.00431034482758621	232	10287	107	ADCY1
R-HSA-432142	Platelet sensitization by LDL	0.321649614371188	-1.13429248003401	17	1	0.00431034482758621	232	10287	338	APOB
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.321790845782894	-1.13385349174304	127	4	0.0172413793103448	232	10287	1490,5244,948,3158	CCN2,ABCB4,CD36,HMGCS2
R-HSA-1483257	Phospholipid metabolism	0.324769100848818	-1.12464080807466	207	6	0.0258620689655172	232	10287	117245,5295,375775,122618,1757,162466	PLAAT5,PIK3R1,PNPLA7,PLD4,SARDH,PHOSPHO1
R-HSA-198203	PI3K/AKT activation	0.326917682011895	-1.11804687674263	128	4	0.0172413793103448	232	10287	2549,5295,3815,2252	GAB1,PIK3R1,KIT,FGF7
R-HSA-180292	GAB1 signalosome	0.326917682011895	-1.11804687674263	128	4	0.0172413793103448	232	10287	5295,2549,3815,2252	PIK3R1,GAB1,KIT,FGF7
R-HSA-2172127	DAP12 interactions	0.327301508149626	-1.11687348963464	371	10	0.0431034482758621	232	10287	3815,816,54209,2905,5136,4684,2252,5295,2549,107	KIT,CAMK2B,TREM2,GRIN2C,PDE1A,NCAM1,FGF7,PIK3R1,GAB1,ADCY1
R-HSA-1483206	Glycerophospholipid biosynthesis	0.332049738418623	-1.1024705067728	129	4	0.0172413793103448	232	10287	162466,1757,122618,117245	PHOSPHO1,SARDH,PLD4,PLAAT5
R-HSA-6806667	Metabolism of fat-soluble vitamins	0.336631358533511	-1.08876683895781	53	2	0.00862068965517241	232	10287	6382,338	SDC1,APOB
R-HSA-197264	Nicotinamide salvaging	0.336973595811872	-1.08775070240596	18	1	0.00431034482758621	232	10287	5740	PTGIS
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.336973595811872	-1.08775070240596	18	1	0.00431034482758621	232	10287	9256	TSPOAP1
R-HSA-912631	Regulation of signaling by CBL	0.336973595811872	-1.08775070240596	18	1	0.00431034482758621	232	10287	5295	PIK3R1
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.336973595811872	-1.08775070240596	18	1	0.00431034482758621	232	10287	929	CD14
R-HSA-196757	Metabolism of folate and pterines	0.336973595811872	-1.08775070240596	18	1	0.00431034482758621	232	10287	10840	ALDH1L1
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.336973595811872	-1.08775070240596	18	1	0.00431034482758621	232	10287	2252	FGF7
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.336973595811872	-1.08775070240596	18	1	0.00431034482758621	232	10287	9256	TSPOAP1
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	0.336973595811872	-1.08775070240596	18	1	0.00431034482758621	232	10287	5295	PIK3R1
R-HSA-1369062	ABC transporters in lipid homeostasis	0.336973595811872	-1.08775070240596	18	1	0.00431034482758621	232	10287	225	ABCD2
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.342325676765551	-1.07199272379785	131	4	0.0172413793103448	232	10287	2252,3815,5295,2549	FGF7,KIT,PIK3R1,GAB1
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.351952866016764	-1.04425801571136	19	1	0.00431034482758621	232	10287	2788	GNG7
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.351952866016764	-1.04425801571136	19	1	0.00431034482758621	232	10287	6382	SDC1
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.351952866016764	-1.04425801571136	19	1	0.00431034482758621	232	10287	6382	SDC1
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.351952866016764	-1.04425801571136	19	1	0.00431034482758621	232	10287	6382	SDC1
R-HSA-416700	Other semaphorin interactions	0.351952866016764	-1.04425801571136	19	1	0.00431034482758621	232	10287	54209	TREM2
R-HSA-877300	Interferon gamma signaling	0.35623536799826	-1.03216362052835	94	3	0.0129310344827586	232	10287	816,4684,2209	CAMK2B,NCAM1,FCGR1A
R-HSA-977443	GABA receptor activation	0.361298510192002	-1.0180507643023	56	2	0.00862068965517241	232	10287	2788,107	GNG7,ADCY1
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.362413531041642	-1.01496936819896	95	3	0.0129310344827586	232	10287	929,5608,948	CD14,MAP2K6,CD36
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.362413531041642	-1.01496936819896	95	3	0.0129310344827586	232	10287	5608,929,948	MAP2K6,CD14,CD36
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.362413531041642	-1.01496936819896	95	3	0.0129310344827586	232	10287	929,5608,948	CD14,MAP2K6,CD36
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.362413531041642	-1.01496936819896	95	3	0.0129310344827586	232	10287	5608,929,948	MAP2K6,CD14,CD36
R-HSA-190241	FGFR2 ligand binding and activation	0.36659514642067	-1.00349718310588	20	1	0.00431034482758621	232	10287	2252	FGF7
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	0.36659514642067	-1.00349718310588	20	1	0.00431034482758621	232	10287	1271	CNTFR
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	0.36659514642067	-1.00349718310588	20	1	0.00431034482758621	232	10287	5608	MAP2K6
R-HSA-194315	Signaling by Rho GTPases	0.369171704339025	-0.996493419758985	427	11	0.0474137931034483	232	10287	10811,54763,57569,4638,57449,10398,1124,115703,3798,401541,84033	NOXA1,ROPN1,ARHGAP20,MYLK,PLEKHG5,MYL9,CHN2,ARHGAP33,KIF5A,CENPP,OBSCN
R-HSA-193704	p75 NTR receptor-mediated signalling	0.374741667768305	-0.981518376353869	97	3	0.0129310344827586	232	10287	84894,57449,84033	LINGO1,PLEKHG5,OBSCN
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	0.380907986196992	-0.965197439067357	21	1	0.00431034482758621	232	10287	2147	F2
R-HSA-445144	Signal transduction by L1	0.380907986196992	-0.965197439067357	21	1	0.00431034482758621	232	10287	4684	NCAM1
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.380907986196992	-0.965197439067357	21	1	0.00431034482758621	232	10287	3714	JAG2
R-HSA-8849932	SALM protein interactions at the synapses	0.380907986196992	-0.965197439067357	21	1	0.00431034482758621	232	10287	2905	GRIN2C
R-HSA-3000480	Scavenging by Class A Receptors	0.380907986196992	-0.965197439067357	21	1	0.00431034482758621	232	10287	338	APOB
R-HSA-2024096	HS-GAG degradation	0.380907986196992	-0.965197439067357	21	1	0.00431034482758621	232	10287	6382	SDC1
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	0.387023192436337	-0.949270658971949	99	3	0.0129310344827586	232	10287	90019,127833,338	SYT8,SYT2,APOB
R-HSA-166520	Signalling by NGF	0.390704219634932	-0.939804476787645	477	12	0.0517241379310345	232	10287	2252,5136,4684,2905,84894,107,2549,84033,5295,3815,57449,816	FGF7,PDE1A,NCAM1,GRIN2C,LINGO1,ADCY1,GAB1,OBSCN,PIK3R1,KIT,PLEKHG5,CAMK2B
R-HSA-193648	NRAGE signals death through JNK	0.39363866604802	-0.932321881718348	60	2	0.00862068965517241	232	10287	57449,84033	PLEKHG5,OBSCN
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.394898766166663	-0.929125835114107	22	1	0.00431034482758621	232	10287	2147	F2
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	0.394898766166663	-0.929125835114107	22	1	0.00431034482758621	232	10287	33	ACADL
R-HSA-202131	Metabolism of nitric oxide	0.394898766166663	-0.929125835114107	22	1	0.00431034482758621	232	10287	5593	PRKG2
R-HSA-373753	Nephrin interactions	0.394898766166663	-0.929125835114107	22	1	0.00431034482758621	232	10287	5295	PIK3R1
R-HSA-203765	eNOS activation and regulation	0.394898766166663	-0.929125835114107	22	1	0.00431034482758621	232	10287	5593	PRKG2
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.394898766166663	-0.929125835114107	22	1	0.00431034482758621	232	10287	5295	PIK3R1
R-HSA-186763	Downstream signal transduction	0.398551253533246	-0.919919172878562	352	9	0.0387931034482759	232	10287	3815,816,2905,2252,4684,5136,5295,107,2549	KIT,CAMK2B,GRIN2C,FGF7,NCAM1,PDE1A,PIK3R1,ADCY1,GAB1
R-HSA-1236975	Antigen processing-Cross presentation	0.399247769060512	-0.918173079728521	101	3	0.0129310344827586	232	10287	948,929,2209	CD36,CD14,FCGR1A
R-HSA-2187338	Visual phototransduction	0.399247769060512	-0.918173079728521	101	3	0.0129310344827586	232	10287	6017,6382,338	RLBP1,SDC1,APOB
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.401610273685523	-0.912273129045566	61	2	0.00862068965517241	232	10287	2209,2214	FCGR1A,FCGR3A
R-HSA-8853659	RET signaling	0.408321296950539	-0.895700921961693	270	7	0.0301724137931034	232	10287	2252,4684,3815,2905,2549,816,5295	FGF7,NCAM1,KIT,GRIN2C,GAB1,CAMK2B,PIK3R1
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	0.408574702484149	-0.895080511182564	23	1	0.00431034482758621	232	10287	6648	SOD2
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.408574702484149	-0.895080511182564	23	1	0.00431034482758621	232	10287	6017	RLBP1
R-HSA-389948	PD-1 signaling	0.408574702484149	-0.895080511182564	23	1	0.00431034482758621	232	10287	5133	PDCD1
R-HSA-3371571	HSF1-dependent transactivation	0.408574702484149	-0.895080511182564	23	1	0.00431034482758621	232	10287	816	CAMK2B
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.408574702484149	-0.895080511182564	23	1	0.00431034482758621	232	10287	2788	GNG7
R-HSA-428930	Thromboxane signalling through TP receptor	0.408574702484149	-0.895080511182564	23	1	0.00431034482758621	232	10287	2788	GNG7
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.408574702484149	-0.895080511182564	23	1	0.00431034482758621	232	10287	9256	TSPOAP1
R-HSA-8863678	Neurodegenerative Diseases	0.408574702484149	-0.895080511182564	23	1	0.00431034482758621	232	10287	6648	SOD2
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.408574702484149	-0.895080511182564	23	1	0.00431034482758621	232	10287	2252	FGF7
R-HSA-171052	LDL-mediated lipid transport	0.421942850277848	-0.862885399998914	24	1	0.00431034482758621	232	10287	338	APOB
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.421942850277848	-0.862885399998914	24	1	0.00431034482758621	232	10287	9256	TSPOAP1
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.421942850277848	-0.862885399998914	24	1	0.00431034482758621	232	10287	929	CD14
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.421942850277848	-0.862885399998914	24	1	0.00431034482758621	232	10287	10398	MYL9
R-HSA-3295583	TRP channels	0.435010107297334	-0.8323860129971	25	1	0.00431034482758621	232	10287	55283	MCOLN3
R-HSA-425410	Metal ion SLC transporters	0.435010107297334	-0.8323860129971	25	1	0.00431034482758621	232	10287	30061	SLC40A1
R-HSA-1296041	Activation of G protein gated Potassium channels	0.435010107297334	-0.8323860129971	25	1	0.00431034482758621	232	10287	2788	GNG7
R-HSA-1296059	G protein gated Potassium channels	0.435010107297334	-0.8323860129971	25	1	0.00431034482758621	232	10287	2788	GNG7
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	0.435010107297334	-0.8323860129971	25	1	0.00431034482758621	232	10287	2788	GNG7
R-HSA-1251985	Nuclear signaling by ERBB4	0.435010107297334	-0.8323860129971	25	1	0.00431034482758621	232	10287	2670	GFAP
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.435010107297334	-0.8323860129971	25	1	0.00431034482758621	232	10287	2252	FGF7
R-HSA-982772	Growth hormone receptor signaling	0.435010107297334	-0.8323860129971	25	1	0.00431034482758621	232	10287	1154	CISH
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.435010107297334	-0.8323860129971	25	1	0.00431034482758621	232	10287	26289	AK5
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.435010107297334	-0.8323860129971	25	1	0.00431034482758621	232	10287	2788	GNG7
R-HSA-177929	Signaling by EGFR	0.437419059001734	-0.826863598296595	364	9	0.0387931034482759	232	10287	816,3815,5295,107,2549,2905,2252,4684,5136	CAMK2B,KIT,PIK3R1,ADCY1,GAB1,GRIN2C,FGF7,NCAM1,PDE1A
R-HSA-975298	Ligand-gated ion channel transport	0.447783217321377	-0.803446053587295	26	1	0.00431034482758621	232	10287	8001	GLRA3
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.447783217321377	-0.803446053587295	26	1	0.00431034482758621	232	10287	6382	SDC1
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.447783217321377	-0.803446053587295	26	1	0.00431034482758621	232	10287	338596	ST8SIA6
R-HSA-4608870	Asymmetric localization of PCP proteins	0.448341742069341	-0.802199520245192	67	2	0.00862068965517241	232	10287	8325,144165	FZD8,PRICKLE1
R-HSA-8856688	Golgi-to-ER retrograde transport	0.453304272644493	-0.791191695435605	110	3	0.0129310344827586	232	10287	113220,5050,3798	KIF12,PAFAH1B3,KIF5A
R-HSA-168898	Toll-Like Receptors Cascades	0.454482297679825	-0.78859631512242	153	4	0.0172413793103448	232	10287	338,948,5608,929	APOB,CD36,MAP2K6,CD14
R-HSA-373755	Semaphorin interactions	0.455932622501566	-0.785410238056995	68	2	0.00862068965517241	232	10287	54209,10398	TREM2,MYL9
R-HSA-5663202	Diseases of signal transduction	0.456787483438599	-0.7835370215442	370	9	0.0387931034482759	232	10287	22943,2252,5295,6017,3549,8325,3714,2549,3815	DKK1,FGF7,PIK3R1,RLBP1,IHH,FZD8,JAG2,GAB1,KIT
R-HSA-1474228	Degradation of the extracellular matrix	0.459193272455433	-0.778284084660248	111	3	0.0129310344827586	232	10287	827,11131,50859	CAPN6,CAPN11,SPOCK3
R-HSA-400685	Sema4D in semaphorin signaling	0.460268773670695	-0.775944669541812	27	1	0.00431034482758621	232	10287	10398	MYL9
R-HSA-6783589	Interleukin-6 family signaling	0.460268773670695	-0.775944669541812	27	1	0.00431034482758621	232	10287	1271	CNTFR
R-HSA-180024	DARPP-32 events	0.460268773670695	-0.775944669541812	27	1	0.00431034482758621	232	10287	84152	PPP1R1B
R-HSA-977606	Regulation of Complement cascade	0.460268773670695	-0.775944669541812	27	1	0.00431034482758621	232	10287	730	C7
R-HSA-388841	Costimulation by the CD28 family	0.463463400992963	-0.76902785935289	69	2	0.00862068965517241	232	10287	5133,5295	PDCD1,PIK3R1
R-HSA-1266738	Developmental Biology	0.466982877952737	-0.761462685898147	1075	25	0.107758620689655	232	10287	2549,6327,6329,948,2905,3851,6768,2049,5608,2051,775,11005,3815,5295,288,2252,4684,5105,816,2042,2044,54209,10398,55740,6326	GAB1,SCN2B,SCN4A,CD36,GRIN2C,KRT4,ST14,EPHB3,MAP2K6,EPHB6,CACNA1C,SPINK5,KIT,PIK3R1,ANK3,FGF7,NCAM1,PCK1,CAMK2B,EPHA3,EPHA5,TREM2,MYL9,ENAH,SCN2A
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.469390119480862	-0.756321045039282	156	4	0.0172413793103448	232	10287	2625,113220,4778,3798	GATA3,KIF12,NFE2,KIF5A
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	0.472473222447777	-0.749774205722459	28	1	0.00431034482758621	232	10287	5050	PAFAH1B3
R-HSA-2022854	Keratan sulfate biosynthesis	0.472473222447777	-0.749774205722459	28	1	0.00431034482758621	232	10287	4958	OMD
R-HSA-264876	Insulin processing	0.472473222447777	-0.749774205722459	28	1	0.00431034482758621	232	10287	3798	KIF5A
R-HSA-174800	Chylomicron-mediated lipid transport	0.472473222447777	-0.749774205722459	28	1	0.00431034482758621	232	10287	338	APOB
R-HSA-5621480	Dectin-2 family	0.472473222447777	-0.749774205722459	28	1	0.00431034482758621	232	10287	143662	MUC15
R-HSA-1483191	Synthesis of PC	0.472473222447777	-0.749774205722459	28	1	0.00431034482758621	232	10287	162466	PHOSPHO1
R-HSA-5576893	Phase 2 - plateau phase	0.472473222447777	-0.749774205722459	28	1	0.00431034482758621	232	10287	775	CACNA1C
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	0.472473222447777	-0.749774205722459	28	1	0.00431034482758621	232	10287	929	CD14
R-HSA-1266695	Interleukin-7 signaling	0.472473222447777	-0.749774205722459	28	1	0.00431034482758621	232	10287	5295	PIK3R1
R-HSA-6803529	FGFR2 alternative splicing	0.472473222447777	-0.749774205722459	28	1	0.00431034482758621	232	10287	80004	ESRP2
R-HSA-372790	Signaling by GPCR	0.474248254886652	-0.746024349906726	1299	30	0.129310344827586	232	10287	2905,2147,886,5745,27334,2788,10268,7504,51554,84152,3815,56656,4987,8622,2252,4684,5136,5295,27115,3549,107,2359,6755,84033,8325,5330,80835,57449,816,2149	GRIN2C,F2,CCKAR,PTH1R,P2RY10,GNG7,RAMP3,XK,ACKR4,PPP1R1B,KIT,OR2S2,OPRL1,PDE8B,FGF7,NCAM1,PDE1A,PIK3R1,PDE7B,IHH,ADCY1,FPR3,SSTR5,OBSCN,FZD8,PLCB2,TAS1R1,PLEKHG5,CAMK2B,F2R
R-HSA-6809371	Formation of the cornified envelope	0.478340107604905	-0.737433277316589	71	2	0.00862068965517241	232	10287	11005,6768	SPINK5,ST14
R-HSA-166054	Activated TLR4 signalling	0.48247193816545	-0.728832519137002	115	3	0.0129310344827586	232	10287	5608,929,948	MAP2K6,CD14,CD36
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.484402865906375	-0.724838350916128	29	1	0.00431034482758621	232	10287	1490	CCN2
R-HSA-196807	Nicotinate metabolism	0.484402865906375	-0.724838350916128	29	1	0.00431034482758621	232	10287	5740	PTGIS
R-HSA-202040	G-protein activation	0.484402865906375	-0.724838350916128	29	1	0.00431034482758621	232	10287	2788	GNG7
R-HSA-525793	Myogenesis	0.484402865906375	-0.724838350916128	29	1	0.00431034482758621	232	10287	5608	MAP2K6
R-HSA-375170	CDO in myogenesis	0.484402865906375	-0.724838350916128	29	1	0.00431034482758621	232	10287	5608	MAP2K6
R-HSA-1482839	Acyl chain remodelling of PE	0.484402865906375	-0.724838350916128	29	1	0.00431034482758621	232	10287	117245	PLAAT5
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.496063865626919	-0.701050599201644	30	1	0.00431034482758621	232	10287	3714	JAG2
R-HSA-420092	Glucagon-type ligand receptors	0.496063865626919	-0.701050599201644	30	1	0.00431034482758621	232	10287	2788	GNG7
R-HSA-112399	IRS-mediated signalling	0.49642573218677	-0.700321389390916	294	7	0.0301724137931034	232	10287	2905,2252,4684,3815,5295,816,2549	GRIN2C,FGF7,NCAM1,KIT,PIK3R1,CAMK2B,GAB1
R-HSA-174824	Lipoprotein metabolism	0.500178092075551	-0.692791059827359	74	2	0.00862068965517241	232	10287	338,5649	APOB,RELN
R-HSA-71387	Metabolism of carbohydrates	0.503616868656684	-0.685939481231776	296	7	0.0301724137931034	232	10287	5105,6382,5260,216,5224,8908,4958	PCK1,SDC1,PHKG1,ALDH1A1,PGAM2,GYG2,OMD
R-HSA-74751	Insulin receptor signalling cascade	0.507200185468978	-0.678849510186912	297	7	0.0301724137931034	232	10287	2549,5295,816,2252,4684,3815,2905	GAB1,PIK3R1,CAMK2B,FGF7,NCAM1,KIT,GRIN2C
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	0.50746224558053	-0.678332963778255	31	1	0.00431034482758621	232	10287	5608	MAP2K6
R-HSA-2022928	HS-GAG biosynthesis	0.50746224558053	-0.678332963778255	31	1	0.00431034482758621	232	10287	6382	SDC1
R-HSA-8875878	MET promotes cell motility	0.50746224558053	-0.678332963778255	31	1	0.00431034482758621	232	10287	2549	GAB1
R-HSA-1839124	FGFR1 mutant receptor activation	0.50746224558053	-0.678332963778255	31	1	0.00431034482758621	232	10287	5295	PIK3R1
R-HSA-948021	Transport to the Golgi and subsequent modification	0.508376774392573	-0.676532424438592	164	4	0.0172413793103448	232	10287	288,338596,57134,79090	ANK3,ST8SIA6,MAN1C1,TRAPPC6A
R-HSA-2428924	IGF1R signaling cascade	0.510775015751945	-0.671826068016959	298	7	0.0301724137931034	232	10287	2549,816,5295,4684,3815,2252,2905	GAB1,CAMK2B,PIK3R1,NCAM1,KIT,FGF7,GRIN2C
R-HSA-2428928	IRS-related events triggered by IGF1R	0.510775015751945	-0.671826068016959	298	7	0.0301724137931034	232	10287	2905,3815,4684,2252,5295,816,2549	GRIN2C,KIT,NCAM1,FGF7,PIK3R1,CAMK2B,GAB1
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.510972267602496	-0.67143996108775	387	9	0.0387931034482759	232	10287	2549,107,5295,4684,5136,2252,2905,816,3815	GAB1,ADCY1,PIK3R1,NCAM1,PDE1A,FGF7,GRIN2C,CAMK2B,KIT
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.514341124626384	-0.664868567067956	299	7	0.0301724137931034	232	10287	2549,5295,816,4684,3815,2252,2905	GAB1,PIK3R1,CAMK2B,NCAM1,KIT,FGF7,GRIN2C
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.514408806614733	-0.664736986036665	76	2	0.00862068965517241	232	10287	57449,84033	PLEKHG5,OBSCN
R-HSA-912526	Interleukin receptor SHC signaling	0.516506688980796	-0.660667039914248	255	6	0.0258620689655172	232	10287	2905,2252,4684,3815,5295,816	GRIN2C,FGF7,NCAM1,KIT,PIK3R1,CAMK2B
R-HSA-70171	Glycolysis	0.518603895261848	-0.656614894795392	32	1	0.00431034482758621	232	10287	5224	PGAM2
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.518603895261848	-0.656614894795392	32	1	0.00431034482758621	232	10287	50859	SPOCK3
R-HSA-168638	NOD1/2 Signaling Pathway	0.518603895261848	-0.656614894795392	32	1	0.00431034482758621	232	10287	5608	MAP2K6
R-HSA-376176	Signaling by Robo receptor	0.518603895261848	-0.656614894795392	32	1	0.00431034482758621	232	10287	55740	ENAH
R-HSA-449147	Signaling by Interleukins	0.52363465074622	-0.646961069240293	525	12	0.0517241379310345	232	10287	948,5295,4684,2252,2905,2162,5608,816,2625,3815,1271,6097	CD36,PIK3R1,NCAM1,FGF7,GRIN2C,F13A1,MAP2K6,CAMK2B,GATA3,KIT,CNTFR,RORC
R-HSA-389356	CD28 co-stimulation	0.529494572629523	-0.635832363984665	33	1	0.00431034482758621	232	10287	5295	PIK3R1
R-HSA-1980145	Signaling by NOTCH2	0.529494572629523	-0.635832363984665	33	1	0.00431034482758621	232	10287	3714	JAG2
R-HSA-1839126	FGFR2 mutant receptor activation	0.529494572629523	-0.635832363984665	33	1	0.00431034482758621	232	10287	2252	FGF7
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.529494572629523	-0.635832363984665	33	1	0.00431034482758621	232	10287	4958	OMD
R-HSA-392518	Signal amplification	0.529494572629523	-0.635832363984665	33	1	0.00431034482758621	232	10287	2788	GNG7
R-HSA-202433	Generation of second messenger molecules	0.529494572629523	-0.635832363984665	33	1	0.00431034482758621	232	10287	55740	ENAH
R-HSA-1483255	PI Metabolism	0.535249422867876	-0.625022429760707	79	2	0.00862068965517241	232	10287	5295,375775	PIK3R1,PNPLA7
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.540139907028869	-0.615927085890582	34	1	0.00431034482758621	232	10287	2252	FGF7
R-HSA-451927	Interleukin-2 signaling	0.543144039255233	-0.610380728561505	262	6	0.0258620689655172	232	10287	816,5295,2905,2252,3815,4684	CAMK2B,PIK3R1,GRIN2C,FGF7,KIT,NCAM1
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.543879122081937	-0.609028258871992	126	3	0.0129310344827586	232	10287	5608,929,948	MAP2K6,CD14,CD36
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	0.555471304585503	-0.587938328148502	82	2	0.00862068965517241	232	10287	3798,113220	KIF5A,KIF12
R-HSA-73933	Resolution of Abasic Sites (AP sites)	0.570658277195244	-0.560964712233182	37	1	0.00431034482758621	232	10287	4913	NTHL1
R-HSA-73884	Base Excision Repair	0.570658277195244	-0.560964712233182	37	1	0.00431034482758621	232	10287	4913	NTHL1
R-HSA-1236974	ER-Phagosome pathway	0.575064819886996	-0.553272514300108	85	2	0.00862068965517241	232	10287	948,929	CD36,CD14
R-HSA-114608	Platelet degranulation	0.57555359401829	-0.552422929146966	132	3	0.0129310344827586	232	10287	7057,948,2162	THBS1,CD36,F13A1
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.576425763198857	-0.550908719119246	271	6	0.0258620689655172	232	10287	2252,3815,4684,2905,816,5295	FGF7,KIT,NCAM1,GRIN2C,CAMK2B,PIK3R1
R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	0.577748576489714	-0.548616493716941	179	4	0.0172413793103448	232	10287	3798,113220,5050,57134	KIF5A,KIF12,PAFAH1B3,MAN1C1
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	0.58987481693752	-0.527844939276773	39	1	0.00431034482758621	232	10287	80835	TAS1R1
R-HSA-69231	Cyclin D associated events in G1	0.58987481693752	-0.527844939276773	39	1	0.00431034482758621	232	10287	1028	CDKN1C
R-HSA-69236	G1 Phase	0.58987481693752	-0.527844939276773	39	1	0.00431034482758621	232	10287	1028	CDKN1C
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.58987481693752	-0.527844939276773	39	1	0.00431034482758621	232	10287	4137	MAPT
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.592352554960764	-0.52365328932864	229	5	0.021551724137931	232	10287	2252,3815,2549,974,5295	FGF7,KIT,GAB1,CD79B,PIK3R1
R-HSA-74752	Signaling by Insulin receptor	0.593466834009004	-0.521773948534304	322	7	0.0301724137931034	232	10287	2549,5295,816,2252,4684,3815,2905	GAB1,PIK3R1,CAMK2B,FGF7,NCAM1,KIT,GRIN2C
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.594024297488038	-0.520835055594057	88	2	0.00862068965517241	232	10287	5105,948	PCK1,CD36
R-HSA-375165	NCAM signaling for neurite out-growth	0.594391730651626	-0.520216697768857	276	6	0.0258620689655172	232	10287	816,2905,775,2252,4684,3815	CAMK2B,GRIN2C,CACNA1C,FGF7,NCAM1,KIT
R-HSA-8856828	Clathrin-mediated endocytosis	0.600882391720977	-0.509356051248541	137	3	0.0129310344827586	232	10287	338,90019,127833	APOB,SYT8,SYT2
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.600882391720977	-0.509356051248541	137	3	0.0129310344827586	232	10287	948,7057,2162	CD36,THBS1,F13A1
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.612347549127206	-0.490455266928001	91	2	0.00862068965517241	232	10287	5608,929	MAP2K6,CD14
R-HSA-6782315	tRNA modification in the nucleus and cytosol	0.617105534171213	-0.482715225665491	42	1	0.00431034482758621	232	10287	57604	TRMT9B
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.617105534171213	-0.482715225665491	42	1	0.00431034482758621	232	10287	2788	GNG7
R-HSA-446203	Asparagine N-linked glycosylation	0.622288221055653	-0.474351915666365	284	6	0.0258620689655172	232	10287	79090,256435,338596,288,57134,129807	TRAPPC6A,ST6GALNAC3,ST8SIA6,ANK3,MAN1C1,NEU4
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.624209903665218	-0.471268583098274	93	2	0.00862068965517241	232	10287	5608,929	MAP2K6,CD14
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.624209903665218	-0.471268583098274	93	2	0.00862068965517241	232	10287	929,5608	CD14,MAP2K6
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	0.625776253152912	-0.468762394851307	43	1	0.00431034482758621	232	10287	2788	GNG7
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.625776253152912	-0.468762394851307	43	1	0.00431034482758621	232	10287	55553	SOX6
R-HSA-5668914	Diseases of metabolism	0.634251449303981	-0.455309795437984	44	1	0.00431034482758621	232	10287	8908	GYG2
R-HSA-917937	Iron uptake and transport	0.634251449303981	-0.455309795437984	44	1	0.00431034482758621	232	10287	30061	SLC40A1
R-HSA-418594	G alpha (i) signalling events	0.641208595678915	-0.444400452723813	242	5	0.021551724137931	232	10287	2788,4987,6755,107,2359	GNG7,OPRL1,SSTR5,ADCY1,FPR3
R-HSA-1433557	Signaling by SCF-KIT	0.641426046312291	-0.444061384015794	337	7	0.0301724137931034	232	10287	2905,3815,4684,2252,5295,816,2549	GRIN2C,KIT,NCAM1,FGF7,PIK3R1,CAMK2B,GAB1
R-HSA-4086400	PCP/CE pathway	0.641476023205534	-0.443983471765974	96	2	0.00862068965517241	232	10287	8325,144165	FZD8,PRICKLE1
R-HSA-6811438	Intra-Golgi traffic	0.642535512934391	-0.442333190690625	45	1	0.00431034482758621	232	10287	57134	MAN1C1
R-HSA-166658	Complement cascade	0.642535512934391	-0.442333190690625	45	1	0.00431034482758621	232	10287	730	C7
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.647091483321584	-0.435267598307361	97	2	0.00862068965517241	232	10287	929,5608	CD14,MAP2K6
R-HSA-446652	Interleukin-1 signaling	0.650632736228213	-0.429809949227167	46	1	0.00431034482758621	232	10287	5608	MAP2K6
R-HSA-180336	SHC1 events in EGFR signaling	0.65195713938299	-0.427776456358918	245	5	0.021551724137931	232	10287	816,2905,4684,3815,2252	CAMK2B,GRIN2C,NCAM1,KIT,FGF7
R-HSA-5673001	RAF/MAP kinase cascade	0.65195713938299	-0.427776456358918	245	5	0.021551724137931	232	10287	816,2905,2252,4684,3815	CAMK2B,GRIN2C,FGF7,NCAM1,KIT
R-HSA-112412	SOS-mediated signalling	0.65195713938299	-0.427776456358918	245	5	0.021551724137931	232	10287	816,4684,3815,2252,2905	CAMK2B,NCAM1,KIT,FGF7,GRIN2C
R-HSA-179812	GRB2 events in EGFR signaling	0.65195713938299	-0.427776456358918	245	5	0.021551724137931	232	10287	816,4684,3815,2252,2905	CAMK2B,NCAM1,KIT,FGF7,GRIN2C
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.653193175503748	-0.425882365730135	197	4	0.0172413793103448	232	10287	2252,3815,5295,2549	FGF7,KIT,PIK3R1,GAB1
R-HSA-195258	RHO GTPase Effectors	0.655587313921047	-0.422223782633657	294	6	0.0258620689655172	232	10287	10398,401541,54763,10811,4638,3798	MYL9,CENPP,ROPN1,NOXA1,MYLK,KIF5A
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.658113951131358	-0.418377184639218	99	2	0.00862068965517241	232	10287	929,5608	CD14,MAP2K6
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.658113951131358	-0.418377184639218	99	2	0.00862068965517241	232	10287	929,5608	CD14,MAP2K6
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.658113951131358	-0.418377184639218	99	2	0.00862068965517241	232	10287	929,5608	CD14,MAP2K6
R-HSA-8948216	Collagen chain trimerization	0.658547315386344	-0.417718907097901	47	1	0.00431034482758621	232	10287	81578	COL21A1
R-HSA-170984	ARMS-mediated activation	0.665969991560244	-0.406510667174228	249	5	0.021551724137931	232	10287	816,2252,4684,3815,2905	CAMK2B,FGF7,NCAM1,KIT,GRIN2C
R-HSA-187706	Signalling to p38 via RIT and RIN	0.665969991560244	-0.406510667174228	249	5	0.021551724137931	232	10287	816,3815,4684,2252,2905	CAMK2B,KIT,NCAM1,FGF7,GRIN2C
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.666283352774652	-0.406040244305306	48	1	0.00431034482758621	232	10287	5608	MAP2K6
R-HSA-380108	Chemokine receptors bind chemokines	0.666283352774652	-0.406040244305306	48	1	0.00431034482758621	232	10287	51554	ACKR4
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.666283352774652	-0.406040244305306	48	1	0.00431034482758621	232	10287	1628	DBP
R-HSA-913531	Interferon Signaling	0.668687724852983	-0.402438106823183	201	4	0.0172413793103448	232	10287	2209,4684,2317,816	FCGR1A,NCAM1,FLNB,CAMK2B
R-HSA-5610787	Hedgehog 'off' state	0.668860380609668	-0.402179939274757	101	2	0.00862068965517241	232	10287	2735,107	GLI1,ADCY1
R-HSA-170968	Frs2-mediated activation	0.669415692450136	-0.401350047918978	250	5	0.021551724137931	232	10287	4684,3815,2252,2905,816	NCAM1,KIT,FGF7,GRIN2C,CAMK2B
R-HSA-5684996	MAPK1/MAPK3 signaling	0.672838224781815	-0.396250357457769	251	5	0.021551724137931	232	10287	816,2252,3815,4684,2905	CAMK2B,FGF7,KIT,NCAM1,GRIN2C
R-HSA-169893	Prolonged ERK activation events	0.676237516290693	-0.391210909190443	252	5	0.021551724137931	232	10287	816,4684,3815,2252,2905	CAMK2B,NCAM1,KIT,FGF7,GRIN2C
R-HSA-2586552	Signaling by Leptin	0.679613500047528	-0.386231024685475	253	5	0.021551724137931	232	10287	2905,2252,4684,3815,816	GRIN2C,FGF7,NCAM1,KIT,CAMK2B
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.681235754934758	-0.383846843410815	50	1	0.00431034482758621	232	10287	5295	PIK3R1
R-HSA-383280	Nuclear Receptor transcription pathway	0.688459873808399	-0.37329824310963	51	1	0.00431034482758621	232	10287	6097	RORC
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	0.688459873808399	-0.37329824310963	51	1	0.00431034482758621	232	10287	2209	FCGR1A
R-HSA-112310	Neurotransmitter Release Cycle	0.688459873808399	-0.37329824310963	51	1	0.00431034482758621	232	10287	9256	TSPOAP1
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.688459873808399	-0.37329824310963	51	1	0.00431034482758621	232	10287	6382	SDC1
R-HSA-167044	Signalling to RAS	0.689601014226796	-0.371642088887222	256	5	0.021551724137931	232	10287	3815,4684,2252,2905,816	KIT,NCAM1,FGF7,GRIN2C,CAMK2B
R-HSA-156580	Phase II conjugation	0.694536520738033	-0.3645105325144	106	2	0.00862068965517241	232	10287	2953,2946	GSTT2,GSTM2
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	0.696078764340857	-0.362292457894233	158	3	0.0129310344827586	232	10287	5166,7351,23539	PDK4,UCP2,SLC16A8
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.696141824720924	-0.362201868255486	258	5	0.021551724137931	232	10287	816,3815,4684,2252,2905	CAMK2B,KIT,NCAM1,FGF7,GRIN2C
R-HSA-382556	ABC-family proteins mediated transport	0.69947083954958	-0.357431173308697	107	2	0.00862068965517241	232	10287	5244,225	ABCB4,ABCD2
R-HSA-75153	Apoptotic execution  phase	0.702422686203293	-0.353219939057387	53	1	0.00431034482758621	232	10287	4137	MAPT
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.709168624918515	-0.343661945864324	54	1	0.00431034482758621	232	10287	6382	SDC1
R-HSA-114604	GPVI-mediated activation cascade	0.709168624918515	-0.343661945864324	54	1	0.00431034482758621	232	10287	5295	PIK3R1
R-HSA-187687	Signalling to ERKs	0.712080351826502	-0.339564520248753	263	5	0.021551724137931	232	10287	816,2905,2252,3815,4684	CAMK2B,GRIN2C,FGF7,KIT,NCAM1
R-HSA-2871796	FCERI mediated MAPK activation	0.718289890397067	-0.330882044346706	265	5	0.021551724137931	232	10287	2905,2252,4684,3815,816	GRIN2C,FGF7,NCAM1,KIT,CAMK2B
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.734663399421168	-0.308342844636194	58	1	0.00431034482758621	232	10287	3714	JAG2
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.734663399421168	-0.308342844636194	58	1	0.00431034482758621	232	10287	3714	JAG2
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.734663399421168	-0.308342844636194	58	1	0.00431034482758621	232	10287	3714	JAG2
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.734663399421168	-0.308342844636194	58	1	0.00431034482758621	232	10287	3714	JAG2
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.734663399421168	-0.308342844636194	58	1	0.00431034482758621	232	10287	3714	JAG2
R-HSA-1280215	Cytokine Signaling in Immune system	0.735157015859223	-0.307671175564952	756	15	0.0646551724137931	232	10287	5608,816,2625,2317,1271,6097,2209,3815,5295,948,2162,2905,1154,4684,2252	MAP2K6,CAMK2B,GATA3,FLNB,CNTFR,RORC,FCGR1A,KIT,PIK3R1,CD36,F13A1,GRIN2C,CISH,NCAM1,FGF7
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.739696966616666	-0.301514681225889	372	7	0.0301724137931034	232	10287	2905,2252,4684,3815,816,5295,2549	GRIN2C,FGF7,NCAM1,KIT,CAMK2B,PIK3R1,GAB1
R-HSA-2142753	Arachidonic acid metabolism	0.740681396406696	-0.300184710510665	59	1	0.00431034482758621	232	10287	5740	PTGIS
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.746563476575741	-0.292274633366434	60	1	0.00431034482758621	232	10287	3549	IHH
R-HSA-1280218	Adaptive Immune System	0.74679635817532	-0.291962743899411	810	16	0.0689655172413793	232	10287	929,5133,4008,2209,3815,948,4068,92591,2549,974,54209,55740,2214,5295,3798,2252	CD14,PDCD1,LMO7,FCGR1A,KIT,CD36,SH2D1A,ASB16,GAB1,CD79B,TREM2,ENAH,FCGR3A,PIK3R1,KIF5A,FGF7
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.752312696631161	-0.284603221473224	61	1	0.00431034482758621	232	10287	2735	GLI1
R-HSA-202403	TCR signaling	0.753673591057006	-0.282795907811202	119	2	0.00862068965517241	232	10287	55740,5295	ENAH,PIK3R1
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.759727545750396	-0.274795402409224	330	6	0.0258620689655172	232	10287	816,5295,2905,2252,4684,3815	CAMK2B,PIK3R1,GRIN2C,FGF7,NCAM1,KIT
R-HSA-8873719	RAB geranylgeranylation	0.768792745361384	-0.262933857685114	64	1	0.00431034482758621	232	10287	25837	RAB26
R-HSA-450294	MAP kinase activation in TLR cascade	0.768792745361384	-0.262933857685114	64	1	0.00431034482758621	232	10287	5608	MAP2K6
R-HSA-1630316	Glycosaminoglycan metabolism	0.77366138121071	-0.256620993095772	124	2	0.00862068965517241	232	10287	6382,4958	SDC1,OMD
R-HSA-194138	Signaling by VEGF	0.779431128369093	-0.249190947987339	338	6	0.0258620689655172	232	10287	5295,816,2905,3815,4684,2252	PIK3R1,CAMK2B,GRIN2C,KIT,NCAM1,FGF7
R-HSA-388396	GPCR downstream signaling	0.780868828667662	-0.247348096298512	974	19	0.0818965517241379	232	10287	5295,27115,107,2359,6755,84033,5330,8622,5136,2149,57449,10268,2147,5745,2788,27334,886,56656,4987	PIK3R1,PDE7B,ADCY1,FPR3,SSTR5,OBSCN,PLCB2,PDE8B,PDE1A,F2R,PLEKHG5,RAMP3,F2,PTH1R,GNG7,P2RY10,CCKAR,OR2S2,OPRL1
R-HSA-5358346	Hedgehog ligand biogenesis	0.784180694066523	-0.243115808061834	67	1	0.00431034482758621	232	10287	3549	IHH
R-HSA-5683057	MAPK family signaling cascades	0.787956827915354	-0.238311977534564	290	5	0.021551724137931	232	10287	3815,4684,2252,2905,816	KIT,NCAM1,FGF7,GRIN2C,CAMK2B
R-HSA-216083	Integrin cell surface interactions	0.78907991903777	-0.236887671709797	68	1	0.00431034482758621	232	10287	7057	THBS1
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.793868397222799	-0.230837578043265	69	1	0.00431034482758621	232	10287	79090	TRAPPC6A
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.798548621514915	-0.224959422116466	70	1	0.00431034482758621	232	10287	81578	COL21A1
R-HSA-400253	Circadian Clock	0.803123028861304	-0.219247365237683	71	1	0.00431034482758621	232	10287	1628	DBP
R-HSA-199977	ER to Golgi Anterograde Transport	0.80609833624915	-0.215549538645649	133	2	0.00862068965517241	232	10287	79090,288	TRAPPC6A,ANK3
R-HSA-774815	Nucleosome assembly	0.807594001576548	-0.213695820039404	72	1	0.00431034482758621	232	10287	401541	CENPP
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.807594001576548	-0.213695820039404	72	1	0.00431034482758621	232	10287	401541	CENPP
R-HSA-1980143	Signaling by NOTCH1	0.811963868601127	-0.208299436607112	73	1	0.00431034482758621	232	10287	3714	JAG2
R-HSA-1169408	ISG15 antiviral mechanism	0.824489348490804	-0.192991055815715	76	1	0.00431034482758621	232	10287	2317	FLNB
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.824489348490804	-0.192991055815715	76	1	0.00431034482758621	232	10287	2317	FLNB
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.828477054983051	-0.188166137148328	77	1	0.00431034482758621	232	10287	10370	CITED2
R-HSA-2262749	Cellular response to hypoxia	0.828477054983051	-0.188166137148328	77	1	0.00431034482758621	232	10287	10370	CITED2
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.832374540110968	-0.183472771053719	78	1	0.00431034482758621	232	10287	493861	EID3
R-HSA-6807878	COPI-mediated anterograde transport	0.836183836512661	-0.178906789937164	79	1	0.00431034482758621	232	10287	288	ANK3
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.853975492829884	-0.157852782525842	84	1	0.00431034482758621	232	10287	5608	MAP2K6
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.853975492829884	-0.157852782525842	84	1	0.00431034482758621	232	10287	5608	MAP2K6
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.853975492829884	-0.157852782525842	84	1	0.00431034482758621	232	10287	5608	MAP2K6
R-HSA-351202	Metabolism of polyamines	0.863712738103394	-0.146515044508492	87	1	0.00431034482758621	232	10287	2593	GAMT
R-HSA-6805567	Keratinization	0.865662027015755	-0.144260715629407	214	3	0.0129310344827586	232	10287	6768,3851,11005	ST14,KRT4,SPINK5
R-HSA-168249	Innate Immune System	0.865901326717106	-0.143984318346732	1285	24	0.103448275862069	232	10287	2209,3815,5023,4353,929,5608,2905,122618,10396,2549,948,2214,816,730,54209,338,79895,2252,11001,5136,4684,5295,107,143662	FCGR1A,KIT,P2RX1,MPO,CD14,MAP2K6,GRIN2C,PLD4,ATP8A1,GAB1,CD36,FCGR3A,CAMK2B,C7,TREM2,APOB,ATP8B4,FGF7,SLC27A2,PDE1A,NCAM1,PIK3R1,ADCY1,MUC15
R-HSA-3371556	Cellular response to heat stress	0.869842262622666	-0.139443391101938	89	1	0.00431034482758621	232	10287	816	CAMK2B
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	0.869842262622666	-0.139443391101938	89	1	0.00431034482758621	232	10287	79090	TRAPPC6A
R-HSA-2980736	Peptide hormone metabolism	0.875697246435665	-0.132734856874039	91	1	0.00431034482758621	232	10287	3798	KIF5A
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	0.878525633921347	-0.129510192587352	92	1	0.00431034482758621	232	10287	146760	RTN4RL1
R-HSA-1474290	Collagen formation	0.881289935336419	-0.12636860918862	93	1	0.00431034482758621	232	10287	81578	COL21A1
R-HSA-5625740	RHO GTPases activate PKNs	0.881289935336419	-0.12636860918862	93	1	0.00431034482758621	232	10287	10398	MYL9
R-HSA-15869	Metabolism of nucleotides	0.891734715907067	-0.114586594327004	97	1	0.00431034482758621	232	10287	26289	AK5
R-HSA-202424	Downstream TCR signaling	0.894199637002744	-0.111826221128722	98	1	0.00431034482758621	232	10287	5295	PIK3R1
R-HSA-390466	Chaperonin-mediated protein folding	0.896608674611011	-0.109135772300896	99	1	0.00431034482758621	232	10287	2788	GNG7
R-HSA-977225	Amyloid fiber formation	0.901264117458057	-0.103956926197138	101	1	0.00431034482758621	232	10287	6622	SNCA
R-HSA-109581	Apoptosis	0.903670918552358	-0.101290013014338	172	2	0.00862068965517241	232	10287	929,4137	CD14,MAPT
R-HSA-597592	Post-translational protein modification	0.904473275649675	-0.100402520575899	1034	18	0.0775862068965517	232	10287	25837,143662,288,157869,9719,2625,7057,146760,10417,493861,79090,2147,129807,256435,338596,415,374907,57134	RAB26,MUC15,ANK3,SBSPON,ADAMTSL2,GATA3,THBS1,RTN4RL1,SPON2,EID3,TRAPPC6A,F2,NEU4,ST6GALNAC3,ST8SIA6,ARSE,B3GNT8,MAN1C1
R-HSA-2132295	MHC class II antigen presentation	0.905710800699393	-0.099035228421823	103	1	0.00431034482758621	232	10287	3798	KIF5A
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	0.905710800699393	-0.099035228421823	103	1	0.00431034482758621	232	10287	401541	CENPP
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	0.907858787167334	-0.0966664332162695	104	1	0.00431034482758621	232	10287	493861	EID3
R-HSA-5357801	Programmed Cell Death	0.908870659849045	-0.0955524833235025	175	2	0.00862068965517241	232	10287	929,4137	CD14,MAPT
R-HSA-391251	Protein folding	0.909958046858121	-0.0943567828877012	105	1	0.00431034482758621	232	10287	2788	GNG7
R-HSA-71291	Metabolism of amino acids and derivatives	0.91453442244922	-0.0893401711278238	361	5	0.021551724137931	232	10287	2593,5053,2875,57571,374569	GAMT,PAH,GPT,CARNS1,ASPG
R-HSA-73886	Chromosome Maintenance	0.917889463362122	-0.0856783058924595	109	1	0.00431034482758621	232	10287	401541	CENPP
R-HSA-72306	tRNA processing	0.917889463362122	-0.0856783058924595	109	1	0.00431034482758621	232	10287	57604	TRMT9B
R-HSA-2990846	SUMOylation	0.919761112449571	-0.0836413030375453	110	1	0.00431034482758621	232	10287	493861	EID3
R-HSA-68877	Mitotic Prometaphase	0.921590278413	-0.0816545376931528	111	1	0.00431034482758621	232	10287	401541	CENPP
R-HSA-157118	Signaling by NOTCH	0.9233779214295	-0.0797166792779455	112	1	0.00431034482758621	232	10287	3714	JAG2
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	0.92512498012403	-0.0778264369491382	113	1	0.00431034482758621	232	10287	7351	UCP2
R-HSA-5653656	Vesicle-mediated transport	0.927294350185601	-0.0754842339524159	650	10	0.0431034482758621	232	10287	57134,3798,79090,338,113220,5050,288,127833,90019,948	MAN1C1,KIF5A,TRAPPC6A,APOB,KIF12,PAFAH1B3,ANK3,SYT2,SYT8,CD36
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.927637691730602	-0.0751140408227884	373	5	0.021551724137931	232	10287	4008,2209,929,92591,948	LMO7,FCGR1A,CD14,ASB16,CD36
R-HSA-6798695	Neutrophil degranulation	0.927869191957557	-0.0748645130735877	487	7	0.0301724137931034	232	10287	11001,79895,10396,948,4353,5023,929	SLC27A2,ATP8B4,ATP8A1,CD36,MPO,P2RX1,CD14
R-HSA-5663220	RHO GTPases Activate Formins	0.931725414117921	-0.0707171277507067	117	1	0.00431034482758621	232	10287	401541	CENPP
R-HSA-199991	Membrane Trafficking	0.938050532405609	-0.0639514589263341	610	9	0.0387931034482759	232	10287	57134,5050,113220,79090,3798,338,288,127833,90019	MAN1C1,PAFAH1B3,KIF12,TRAPPC6A,KIF5A,APOB,ANK3,SYT2,SYT8
R-HSA-2559580	Oxidative Stress Induced Senescence	0.944534169339005	-0.0570634155228965	126	1	0.00431034482758621	232	10287	5608	MAP2K6
R-HSA-2262752	Cellular responses to stress	0.945017671216023	-0.0565516519637362	451	6	0.0258620689655172	232	10287	6648,10370,5608,816,50507,2878	SOD2,CITED2,MAP2K6,CAMK2B,NOX4,GPX3
R-HSA-1500931	Cell-Cell communication	0.952816738777698	-0.0483326931086928	133	1	0.00431034482758621	232	10287	5295	PIK3R1
R-HSA-453279	Mitotic G1-G1/S phases	0.96255761029195	-0.0381613597626486	143	1	0.00431034482758621	232	10287	1028	CDKN1C
R-HSA-5621481	C-type lectin receptors (CLRs)	0.963413942532405	-0.037272112675246	144	1	0.00431034482758621	232	10287	143662	MUC15
R-HSA-168256	Immune System	0.966534258877322	-0.034038534632602	2101	37	0.15948275862069	232	10287	5133,5608,929,4008,122618,948,2549,10396,2162,2625,816,2317,6097,55740,338,3798,1154,5136,4353,5023,1271,3815,2209,92591,4068,2905,730,974,54209,2214,5295,107,143662,11001,79895,2252,4684	PDCD1,MAP2K6,CD14,LMO7,PLD4,CD36,GAB1,ATP8A1,F13A1,GATA3,CAMK2B,FLNB,RORC,ENAH,APOB,KIF5A,CISH,PDE1A,MPO,P2RX1,CNTFR,KIT,FCGR1A,ASB16,SH2D1A,GRIN2C,C7,CD79B,TREM2,FCGR3A,PIK3R1,ADCY1,MUC15,SLC27A2,ATP8B4,FGF7,NCAM1
R-HSA-5633007	Regulation of TP53 Activity	0.97588534814428	-0.0244101706329698	162	1	0.00431034482758621	232	10287	5608	MAP2K6
R-HSA-2467813	Separation of Sister Chromatids	0.979017184325147	-0.0212060836688579	168	1	0.00431034482758621	232	10287	401541	CENPP
R-HSA-68882	Mitotic Anaphase	0.983744338141979	-0.016389234650081	179	1	0.00431034482758621	232	10287	401541	CENPP
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.984117439992266	-0.016010039465843	180	1	0.00431034482758621	232	10287	401541	CENPP
R-HSA-2559583	Cellular Senescence	0.989049431776895	-0.0110109670342513	196	1	0.00431034482758621	232	10287	5608	MAP2K6
R-HSA-5663205	Infectious disease	0.993568288940592	-0.00645248362966662	388	3	0.0129310344827586	232	10287	5608,9899,127833	MAP2K6,SV2B,SYT2
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.993754332191861	-0.00626525358474725	311	2	0.00862068965517241	232	10287	92591,4008	ASB16,LMO7
R-HSA-5689880	Ub-specific processing proteases	0.994160920639645	-0.00585619343706324	223	1	0.00431034482758621	232	10287	2625	GATA3
R-HSA-5688426	Deubiquitination	0.999059784521681	-0.000940657758139423	301	1	0.00431034482758621	232	10287	2625	GATA3
R-HSA-392499	Metabolism of proteins	0.999071296700505	-0.000929134811589578	1619	21	0.0905172413793103	232	10287	288,157869,9719,3798,25837,143662,6622,10417,146760,2625,7057,2147,2788,79090,493861,338596,415,374907,57134,256435,129807	ANK3,SBSPON,ADAMTSL2,KIF5A,RAB26,MUC15,SNCA,SPON2,RTN4RL1,GATA3,THBS1,F2,GNG7,TRAPPC6A,EID3,ST8SIA6,ARSE,B3GNT8,MAN1C1,ST6GALNAC3,NEU4
R-HSA-68886	M Phase	0.999202475573831	-0.000797842617962076	308	1	0.00431034482758621	232	10287	401541	CENPP
R-HSA-73894	DNA Repair	0.99933932706428	-0.000660891276256801	316	1	0.00431034482758621	232	10287	4913	NTHL1
R-HSA-3700989	Transcriptional Regulation by TP53	0.999801748186438	-0.000198271468050078	367	1	0.00431034482758621	232	10287	5608	MAP2K6
R-HSA-381753	Olfactory Signaling Pathway	0.99988772933335	-0.000112276969473009	391	1	0.00431034482758621	232	10287	56656	OR2S2
R-HSA-69278	Cell Cycle, Mitotic	0.999919592348575	-8.041088429385e-05	514	2	0.00862068965517241	232	10287	1028,401541	CDKN1C,CENPP
R-HSA-212436	Generic Transcription Pathway	0.999987671146731	-1.23289292697619e-05	865	5	0.021551724137931	232	10287	3815,1490,10370,6097,5608	KIT,CCN2,CITED2,RORC,MAP2K6
R-HSA-1640170	Cell Cycle	0.999992691494364	-7.30853234357818e-06	621	2	0.00862068965517241	232	10287	1028,401541	CDKN1C,CENPP
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	0.999999999979042	-2.09577050853847e-11	29	0	0	232	10287
R-HSA-5218920	VEGFR2 mediated vascular permeability	0.999999999979042	-2.09577050853847e-11	29	0	0	232	10287
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.999999999979042	-2.09577050853847e-11	29	0	0	232	10287
R-HSA-72086	mRNA Capping	0.999999999979042	-2.09577050853847e-11	29	0	0	232	10287
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.999999999979042	-2.09577050853847e-11	29	0	0	232	10287
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.999999999979042	-2.09577050853847e-11	29	0	0	232	10287
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.999999999979042	-2.09577050853847e-11	29	0	0	232	10287
R-HSA-8937144	Aryl hydrocarbon receptor signalling	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-804914	Transport of fatty acids	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-444821	Relaxin receptors	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-977347	Serine biosynthesis	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-1483115	Hydrolysis of LPC	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-68952	DNA replication initiation	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-5576890	Phase 3 - rapid repolarisation	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-448424	Interleukin-17 signaling	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-164944	Nef and signal transduction	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-72731	Recycling of eIF2:GDP	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-2142789	Ubiquinol biosynthesis	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-2408508	Metabolism of ingested SeMet, Sec, MeSec into H2Se	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-196783	Coenzyme A biosynthesis	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-194313	VEGF ligand-receptor interactions	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-6787450	tRNA modification in the mitochondrion	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-177128	Conjugation of salicylate with glycine	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-1253288	Downregulation of ERBB4 signaling	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-73942	DNA Damage Reversal	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-174430	Telomere C-strand synthesis initiation	0.99999999997916	-2.08403280730793e-11	8	0	0	232	10287
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.999999999980105	-1.98949929314349e-11	30	0	0	232	10287
R-HSA-8863795	Downregulation of ERBB2 signaling	0.999999999980105	-1.98949929314349e-11	30	0	0	232	10287
R-HSA-381042	PERK regulates gene expression	0.999999999980105	-1.98949929314349e-11	30	0	0	232	10287
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.999999999980105	-1.98949929314349e-11	30	0	0	232	10287
R-HSA-5669034	TNFs bind their physiological receptors	0.999999999980105	-1.98949929314349e-11	30	0	0	232	10287
R-HSA-420029	Tight junction interactions	0.999999999980105	-1.98949929314349e-11	30	0	0	232	10287
R-HSA-917977	Transferrin endocytosis and recycling	0.999999999980105	-1.98949929314349e-11	30	0	0	232	10287
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.999999999980105	-1.98949929314349e-11	30	0	0	232	10287
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	0.999999999980105	-1.98949929314349e-11	30	0	0	232	10287
R-HSA-5683826	Surfactant metabolism	0.999999999980105	-1.98949929314349e-11	30	0	0	232	10287
R-HSA-157858	Gap junction trafficking and regulation	0.999999999980105	-1.98949929314349e-11	30	0	0	232	10287
R-HSA-74160	Gene Expression	0.999999999981001	-1.89993991592578e-11	1821	6	0.0258620689655172	232	10287	5608,57604,6097,3815,1490,10370	MAP2K6,TRMT9B,RORC,KIT,CCN2,CITED2
R-HSA-73847	Purine metabolism	0.999999999988431	-1.1568576880161e-11	34	0	0	232	10287
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.999999999988431	-1.1568576880161e-11	34	0	0	232	10287
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.999999999988431	-1.1568576880161e-11	34	0	0	232	10287
R-HSA-5656169	Termination of translesion DNA synthesis	0.999999999988431	-1.1568576880161e-11	34	0	0	232	10287
R-HSA-1483166	Synthesis of PA	0.999999999988431	-1.1568576880161e-11	34	0	0	232	10287
R-HSA-113510	E2F mediated regulation of DNA replication	0.999999999988431	-1.1568576880161e-11	34	0	0	232	10287
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.999999999988431	-1.1568576880161e-11	34	0	0	232	10287
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	0.999999999988431	-1.1568576880161e-11	34	0	0	232	10287
R-HSA-5694530	Cargo concentration in the ER	0.999999999988431	-1.1568576880161e-11	34	0	0	232	10287
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.999999999988431	-1.1568576880161e-11	34	0	0	232	10287
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.999999999988431	-1.1568576880161e-11	34	0	0	232	10287
R-HSA-157579	Telomere Maintenance	0.999999999990763	-9.23679251893436e-12	82	0	0	232	10287
R-HSA-380287	Centrosome maturation	0.999999999990763	-9.23679251893436e-12	82	0	0	232	10287
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.999999999990763	-9.23679251893436e-12	82	0	0	232	10287
R-HSA-75109	Triglyceride Biosynthesis	0.999999999990763	-9.23679251893436e-12	82	0	0	232	10287
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.999999999990763	-9.23679251893436e-12	82	0	0	232	10287
R-HSA-69091	Polymerase switching	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-209952	Peptide hormone biosynthesis	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-1679131	Trafficking and processing of endosomal TLR	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-177504	Retrograde neurotrophin signalling	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-2024101	CS/DS degradation	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-209543	p75NTR recruits signalling complexes	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-418885	DCC mediated attractive signaling	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-428790	Facilitative Na+-independent glucose transporters	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-419408	Lysosphingolipid and LPA receptors	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-190322	FGFR4 ligand binding and activation	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-877312	Regulation of IFNG signaling	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-428540	Activation of Rac	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-69166	Removal of the Flap Intermediate	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-5675482	Regulation of necroptotic cell death	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-209560	NF-kB is activated and signals survival	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-162594	Early Phase of HIV Life Cycle	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-69109	Leading Strand Synthesis	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-174403	Glutathione synthesis and recycling	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.999999999990901	-9.09946989434127e-12	14	0	0	232	10287
R-HSA-114452	Activation of BH3-only proteins	0.999999999991373	-8.62694792472001e-12	31	0	0	232	10287
R-HSA-73772	RNA Polymerase I Promoter Escape	0.999999999991373	-8.62694792472001e-12	31	0	0	232	10287
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	0.999999999991373	-8.62694792472001e-12	31	0	0	232	10287
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.999999999991373	-8.62694792472001e-12	31	0	0	232	10287
R-HSA-5654733	Negative regulation of FGFR4 signaling	0.999999999991373	-8.62694792472001e-12	31	0	0	232	10287
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	0.999999999991373	-8.62694792472001e-12	31	0	0	232	10287
R-HSA-180786	Extension of Telomeres	0.999999999991373	-8.62694792472001e-12	31	0	0	232	10287
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	0.999999999991373	-8.62694792472001e-12	31	0	0	232	10287
R-HSA-418990	Adherens junctions interactions	0.999999999991373	-8.62694792472001e-12	31	0	0	232	10287
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	0.999999999991373	-8.62694792472001e-12	31	0	0	232	10287
R-HSA-5621575	CD209 (DC-SIGN) signaling	0.999999999993173	-6.82705833728576e-12	22	0	0	232	10287
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.999999999993173	-6.82705833728576e-12	22	0	0	232	10287
R-HSA-389513	CTLA4 inhibitory signaling	0.999999999993173	-6.82705833728576e-12	22	0	0	232	10287
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.999999999993173	-6.82705833728576e-12	22	0	0	232	10287
R-HSA-5620916	VxPx cargo-targeting to cilium	0.999999999993173	-6.82705833728576e-12	22	0	0	232	10287
R-HSA-1482801	Acyl chain remodelling of PS	0.999999999993173	-6.82705833728576e-12	22	0	0	232	10287
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.999999999993173	-6.82705833728576e-12	22	0	0	232	10287
R-HSA-166208	mTORC1-mediated signalling	0.999999999993173	-6.82705833728576e-12	22	0	0	232	10287
R-HSA-166663	Initial triggering of complement	0.999999999993173	-6.82705833728576e-12	22	0	0	232	10287
R-HSA-198753	ERK/MAPK targets	0.999999999993173	-6.82705833728576e-12	22	0	0	232	10287
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.999999999993173	-6.82705833728576e-12	22	0	0	232	10287
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.999999999993173	-6.82705833728576e-12	22	0	0	232	10287
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.999999999993173	-6.82705833728576e-12	22	0	0	232	10287
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.999999999993173	-6.82705833728576e-12	22	0	0	232	10287
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	0.999999999993173	-6.82705833728576e-12	22	0	0	232	10287
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-211227	Activation of DNA fragmentation factor	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-202670	ERKs are inactivated	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-5357786	TNFR1-induced proapoptotic signaling	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-375281	Hormone ligand-binding receptors	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-350054	Notch-HLH transcription pathway	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-74217	Purine salvage	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-3270619	IRF3-mediated induction of type I IFN	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-190239	FGFR3 ligand binding and activation	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-2168880	Scavenging of heme from plasma	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-71240	Tryptophan catabolism	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-190375	FGFR2c ligand binding and activation	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-2408517	SeMet incorporation into proteins	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-140342	Apoptosis induced DNA fragmentation	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-5626467	RHO GTPases activate IQGAPs	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-190372	FGFR3c ligand binding and activation	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-175474	Assembly Of The HIV Virion	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-75205	Dissolution of Fibrin Clot	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-5658623	FGFRL1 modulation of FGFR1 signaling	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-171007	p38MAPK events	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-2995410	Nuclear Envelope Reassembly	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-75892	Platelet Adhesion to exposed collagen	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-198323	AKT phosphorylates targets in the cytosol	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-977441	GABA A receptor activation	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-1502540	Signaling by Activin	0.999999999993278	-6.72162417845102e-12	13	0	0	232	10287
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.999999999993549	-6.450724449199e-12	60	0	0	232	10287
R-HSA-6784531	tRNA processing in the nucleus	0.999999999993549	-6.450724449199e-12	60	0	0	232	10287
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.999999999993549	-6.450724449199e-12	60	0	0	232	10287
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.999999999993549	-6.450724449199e-12	60	0	0	232	10287
R-HSA-69002	DNA Replication Pre-Initiation	0.999999999993628	-6.37213324281107e-12	86	0	0	232	10287
R-HSA-68874	M/G1 Transition	0.999999999993628	-6.37213324281107e-12	86	0	0	232	10287
R-HSA-6802949	Signaling by RAS mutants	0.999999999994325	-5.6747724737359e-12	50	0	0	232	10287
R-HSA-167169	HIV Transcription Elongation	0.999999999994325	-5.6747724737359e-12	50	0	0	232	10287
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	0.999999999994325	-5.6747724737359e-12	50	0	0	232	10287
R-HSA-73893	DNA Damage Bypass	0.999999999994325	-5.6747724737359e-12	50	0	0	232	10287
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	0.999999999994325	-5.6747724737359e-12	50	0	0	232	10287
R-HSA-73887	Death Receptor Signalling	0.999999999994325	-5.6747724737359e-12	50	0	0	232	10287
R-HSA-437239	Recycling pathway of L1	0.999999999995644	-4.35587120228478e-12	28	0	0	232	10287
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	0.999999999995644	-4.35587120228478e-12	28	0	0	232	10287
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	0.999999999995644	-4.35587120228478e-12	28	0	0	232	10287
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	0.999999999995644	-4.35587120228478e-12	28	0	0	232	10287
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	0.999999999995644	-4.35587120228478e-12	28	0	0	232	10287
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	0.999999999995644	-4.35587120228478e-12	28	0	0	232	10287
R-HSA-1368082	RORA activates gene expression	0.999999999995644	-4.35587120228478e-12	28	0	0	232	10287
R-HSA-354192	Integrin alphaIIb beta3 signaling	0.999999999995644	-4.35587120228478e-12	28	0	0	232	10287
R-HSA-190828	Gap junction trafficking	0.999999999995644	-4.35587120228478e-12	28	0	0	232	10287
R-HSA-6809583	Retinoid metabolism disease events	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-5083629	Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-3248023	Regulation by TREX1	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-1839128	FGFR4 mutant receptor activation	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-162585	Uncoating of the HIV Virion	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-1855231	Synthesis of IPs in the ER lumen	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-2408552	Methylation of MeSeH for excretion	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-5657655	MGMT-mediated DNA damage reversal	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-389542	NADPH regeneration	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-1839120	Signaling by FGFR1 amplification mutants	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-5263617	Metabolism of ingested MeSeO2H into MeSeH	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-169131	Inhibition of PKR	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-163316	Mitochondrial transcription termination	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-162589	Reverse Transcription of HIV RNA	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-171286	Synthesis and processing of ENV and VPU	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-164525	Plus-strand DNA synthesis	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-5602415	UNC93B1 deficiency - HSE	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-1222499	Response of Mtb to phagocytosis	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-1222449	Mtb iron assimilation by chelation	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-8853333	Signaling by FGFR2 fusions	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-2033515	t(4;14) translocations of FGFR3	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-5602410	TLR3 deficiency - HSE	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-164516	Minus-strand DNA synthesis	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-1300645	Acrosome Reaction	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-140180	COX reactions	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-1483076	Synthesis of CL	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-2534343	Interaction With Cumulus Cells	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-5083633	Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-5083628	Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.999999999996131	-3.86909254634915e-12	1	0	0	232	10287
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-428808	Na+-dependent glucose transporters	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-388479	Vasopressin-like receptors	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-3323169	Defects in biotin (Btn) metabolism	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-205025	NADE modulates death signalling	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-177135	Conjugation of benzoate with glycine	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-947581	Molybdenum cofactor biosynthesis	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-5676934	Protein repair	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-189483	Heme degradation	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-5626978	TNFR1-mediated ceramide production	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-6793080	rRNA modification in the mitochondrion	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-8857538	PTK6 promotes HIF1A stabilization	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-193993	Mineralocorticoid biosynthesis	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-190370	FGFR1b ligand binding and activation	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-444257	RSK activation	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-500753	Pyrimidine biosynthesis	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-5660668	CLEC7A/inflammasome pathway	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-5336415	Uptake and function of diphtheria toxin	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-446199	Synthesis of Dolichyl-phosphate	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-8849470	PTK6 Regulates Cell Cycle	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-6787639	GDP-fucose biosynthesis	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-1237112	Methionine salvage pathway	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-187015	Activation of TRKA receptors	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-176417	Phosphorylation of Emi1	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-6799990	Metal sequestration by antimicrobial proteins	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-166662	Lectin pathway of complement activation	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-1482798	Acyl chain remodeling of CL	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-173623	Classical antibody-mediated complement activation	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-1566977	Fibronectin matrix formation	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-3065679	SUMO is proteolytically processed	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-211916	Vitamins	0.999999999996203	-3.79707767620406e-12	6	0	0	232	10287
R-HSA-156842	Eukaryotic Translation Elongation	0.999999999996218	-3.78203995945214e-12	96	0	0	232	10287
R-HSA-72764	Eukaryotic Translation Termination	0.999999999996218	-3.78203995945214e-12	96	0	0	232	10287
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	0.999999999996431	-3.56910016766523e-12	19	0	0	232	10287
R-HSA-71403	Citric acid cycle (TCA cycle)	0.999999999996431	-3.56910016766523e-12	19	0	0	232	10287
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	0.999999999996431	-3.56910016766523e-12	19	0	0	232	10287
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.999999999996431	-3.56910016766523e-12	19	0	0	232	10287
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.999999999996431	-3.56910016766523e-12	19	0	0	232	10287
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.999999999996431	-3.56910016766523e-12	19	0	0	232	10287
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.999999999996431	-3.56910016766523e-12	19	0	0	232	10287
R-HSA-5223345	Miscellaneous transport and binding events	0.999999999996431	-3.56910016766523e-12	19	0	0	232	10287
R-HSA-190861	Gap junction assembly	0.999999999996431	-3.56910016766523e-12	19	0	0	232	10287
R-HSA-8876725	Protein methylation	0.999999999996431	-3.56910016766523e-12	19	0	0	232	10287
R-HSA-8851708	Signaling by FGFR2 IIIa TM	0.999999999996431	-3.56910016766523e-12	19	0	0	232	10287
R-HSA-156584	Cytosolic sulfonation of small molecules	0.999999999996431	-3.56910016766523e-12	19	0	0	232	10287
R-HSA-176412	Phosphorylation of the APC/C	0.999999999996431	-3.56910016766523e-12	19	0	0	232	10287
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	0.999999999996431	-3.56910016766523e-12	19	0	0	232	10287
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.999999999996431	-3.56910016766523e-12	19	0	0	232	10287
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	0.999999999996431	-3.56910016766523e-12	19	0	0	232	10287
R-HSA-110320	Translesion Synthesis by POLH	0.999999999996431	-3.56910016766523e-12	19	0	0	232	10287
R-HSA-1538133	G0 and Early G1	0.999999999996757	-3.24311187422537e-12	25	0	0	232	10287
R-HSA-3000157	Laminin interactions	0.999999999996757	-3.24311187422537e-12	25	0	0	232	10287
R-HSA-429947	Deadenylation of mRNA	0.999999999996757	-3.24311187422537e-12	25	0	0	232	10287
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.999999999996757	-3.24311187422537e-12	25	0	0	232	10287
R-HSA-1614635	Sulfur amino acid metabolism	0.999999999996757	-3.24311187422537e-12	25	0	0	232	10287
R-HSA-389661	Glyoxylate metabolism and glycine degradation	0.999999999996757	-3.24311187422537e-12	25	0	0	232	10287
R-HSA-5673000	RAF activation	0.999999999996757	-3.24311187422537e-12	25	0	0	232	10287
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	0.999999999996757	-3.24311187422537e-12	25	0	0	232	10287
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	0.999999999996757	-3.24311187422537e-12	25	0	0	232	10287
R-HSA-203927	MicroRNA (miRNA) biogenesis	0.999999999996757	-3.24311187422537e-12	25	0	0	232	10287
R-HSA-933542	TRAF6 mediated NF-kB activation	0.999999999996757	-3.24311187422537e-12	25	0	0	232	10287
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.999999999996757	-3.24311187422537e-12	25	0	0	232	10287
R-HSA-211981	Xenobiotics	0.999999999996757	-3.24311187422537e-12	25	0	0	232	10287
R-HSA-182971	EGFR downregulation	0.999999999996757	-3.24311187422537e-12	25	0	0	232	10287
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	0.999999999996757	-3.24311187422537e-12	25	0	0	232	10287
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.999999999996757	-3.24311187422537e-12	25	0	0	232	10287
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.999999999996757	-3.24311187422537e-12	25	0	0	232	10287
R-HSA-162588	Budding and maturation of HIV virion	0.999999999996757	-3.24311187422537e-12	25	0	0	232	10287
R-HSA-446353	Cell-extracellular matrix interactions	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-399956	CRMPs in Sema3A signaling	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-1834941	STING mediated induction of host immune responses	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-1295596	Spry regulation of FGF signaling	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-392517	Rap1 signalling	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-190242	FGFR1 ligand binding and activation	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-5218859	Regulated Necrosis	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-159418	Recycling of bile acids and salts	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-1170546	Prolactin receptor signaling	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-110312	Translesion synthesis by REV1	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.999999999996966	-3.03434218142391e-12	16	0	0	232	10287
R-HSA-70153	Glucose transport	0.999999999997569	-2.43152723397051e-12	46	0	0	232	10287
R-HSA-4615885	SUMOylation of DNA replication proteins	0.999999999997569	-2.43152723397051e-12	46	0	0	232	10287
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.999999999997569	-2.43152723397051e-12	46	0	0	232	10287
R-HSA-5674135	MAP2K and MAPK activation	0.999999999997896	-2.10406112499966e-12	39	0	0	232	10287
R-HSA-6783310	Fanconi Anemia Pathway	0.999999999997896	-2.10406112499966e-12	39	0	0	232	10287
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	0.999999999997896	-2.10406112499966e-12	39	0	0	232	10287
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	0.999999999997896	-2.10406112499966e-12	39	0	0	232	10287
R-HSA-5696394	DNA Damage Recognition in GG-NER	0.999999999997896	-2.10406112499966e-12	39	0	0	232	10287
R-HSA-165159	mTOR signalling	0.999999999997896	-2.10406112499966e-12	39	0	0	232	10287
R-HSA-73728	RNA Polymerase I Promoter Opening	0.999999999997897	-2.1032152285337e-12	63	0	0	232	10287
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	0.999999999997897	-2.1032152285337e-12	63	0	0	232	10287
R-HSA-5654693	FRS-mediated FGFR1 signaling	0.999999999998379	-1.62064800557035e-12	23	0	0	232	10287
R-HSA-400508	Incretin synthesis, secretion, and inactivation	0.999999999998379	-1.62064800557035e-12	23	0	0	232	10287
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.999999999998379	-1.62064800557035e-12	23	0	0	232	10287
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.999999999998379	-1.62064800557035e-12	23	0	0	232	10287
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	0.999999999998379	-1.62064800557035e-12	23	0	0	232	10287
R-HSA-73980	RNA Polymerase III Transcription Termination	0.999999999998379	-1.62064800557035e-12	23	0	0	232	10287
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	0.999999999998379	-1.62064800557035e-12	23	0	0	232	10287
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.999999999998379	-1.62064800557035e-12	23	0	0	232	10287
R-HSA-5205647	Mitophagy	0.999999999998379	-1.62064800557035e-12	23	0	0	232	10287
R-HSA-379726	Mitochondrial tRNA aminoacylation	0.999999999998379	-1.62064800557035e-12	23	0	0	232	10287
R-HSA-112409	RAF-independent MAPK1/3 activation	0.999999999998379	-1.62064800557035e-12	23	0	0	232	10287
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.99999999999853	-1.46982805053921e-12	24	0	0	232	10287
R-HSA-156588	Glucuronidation	0.99999999999853	-1.46982805053921e-12	24	0	0	232	10287
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	0.99999999999853	-1.46982805053921e-12	24	0	0	232	10287
R-HSA-70895	Branched-chain amino acid catabolism	0.99999999999853	-1.46982805053921e-12	24	0	0	232	10287
R-HSA-191273	Cholesterol biosynthesis	0.99999999999853	-1.46982805053921e-12	24	0	0	232	10287
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	0.999999999999072	-9.28232558430089e-13	41	0	0	232	10287
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.999999999999072	-9.28232558430089e-13	41	0	0	232	10287
R-HSA-5696400	Dual Incision in GG-NER	0.999999999999072	-9.28232558430089e-13	41	0	0	232	10287
R-HSA-5620924	Intraflagellar transport	0.999999999999072	-9.28232558430089e-13	41	0	0	232	10287
R-HSA-74158	RNA Polymerase III Transcription	0.999999999999072	-9.28232558430089e-13	41	0	0	232	10287
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-2046105	Linoleic acid (LA) metabolism	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-110056	MAPK3 (ERK1) activation	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-209968	Thyroxine biosynthesis	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-8868766	rRNA processing in the mitochondrion	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-1300644	Interaction With The Zona Pellucida	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-74259	Purine catabolism	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-428643	Organic anion transporters	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-418886	Netrin mediated repulsion signals	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-70635	Urea cycle	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-201688	WNT mediated activation of DVL	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-190873	Gap junction degradation	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-193692	Regulated proteolysis of p75NTR	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-3215018	Processing and activation of SUMO	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-390450	Folding of actin by CCT/TriC	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-74749	Signal attenuation	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-5687613	Diseases associated with surfactant metabolism	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-727802	Transport of nucleotide sugars	0.99999999999935	-6.50511574727207e-13	10	0	0	232	10287
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	1.00000000000012	1.20747552135174e-13	64	0	0	232	10287
R-HSA-4570464	SUMOylation of RNA binding proteins	1.00000000000048	4.83215031875631e-13	48	0	0	232	10287
R-HSA-73762	RNA Polymerase I Transcription Initiation	1.00000000000048	4.83215031875631e-13	48	0	0	232	10287
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	1.00000000000048	4.83215031875631e-13	48	0	0	232	10287
R-HSA-168277	Influenza Virus Induced Apoptosis	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-141424	Amplification of signal from the kinetochores	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-8854521	Interaction between PHLDA1 and AURKA	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-451307	Activation of Na-permeable Kainate Receptors	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-203754	NOSIP mediated eNOS trafficking	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-916853	Degradation of GABA	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-71737	Pyrophosphate hydrolysis	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-190872	Transport of connexons to the plasma membrane	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-1483101	Synthesis of PS	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-141334	PAOs oxidise polyamines to amines	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-1483152	Hydrolysis of LPE	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-198765	Signalling to ERK5	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-5683177	Defective ABCC8 can cause hypoglycemias and hyperglycemias	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-888568	GABA synthesis	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-5652227	Fructose biosynthesis	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-165160	PDE3B signalling	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-70688	Proline catabolism	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-6804754	Regulation of TP53 Expression	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-351143	Agmatine biosynthesis	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-5602566	TICAM1 deficiency - HSE	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-75896	Plasmalogen biosynthesis	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-205017	NFG and proNGF binds to p75NTR	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-75064	mRNA Editing: A to I Conversion	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-168268	Virus Assembly and Release	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-844623	The IPAF inflammasome	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-8849175	Threonine catabolism	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-75102	C6 deamination of adenosine	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-187042	TRKA activation by NGF	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-1614603	Cysteine formation from homocysteine	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-428559	Proton-coupled neutral amino acid transporters	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-114294	Activation, translocation and oligomerization of BAX	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-156582	Acetylation	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-8942233	Intestinal infectious diseases	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-111457	Release of apoptotic factors from the mitochondria	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-380612	Metabolism of serotonin	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-192905	vRNP Assembly	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-5602636	IKBKB deficiency causes SCID	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-168316	Assembly of Viral Components at the Budding Site	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-177162	Conjugation of phenylacetate with glutamine	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-111995	phospho-PLA2 pathway	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-111452	Activation and oligomerization of BAK protein	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-77042	Formation of editosomes by ADAR proteins	1.00000000000061	6.11621539005347e-13	2	0	0	232	10287
R-HSA-5654704	SHC-mediated cascade:FGFR3	1.00000000000129	1.2894445157502e-12	18	0	0	232	10287
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	1.00000000000129	1.2894445157502e-12	18	0	0	232	10287
R-HSA-209776	Amine-derived hormones	1.00000000000129	1.2894445157502e-12	18	0	0	232	10287
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	1.00000000000129	1.2894445157502e-12	18	0	0	232	10287
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	1.00000000000129	1.2894445157502e-12	18	0	0	232	10287
R-HSA-1912420	Pre-NOTCH Processing in Golgi	1.00000000000129	1.2894445157502e-12	18	0	0	232	10287
R-HSA-69205	G1/S-Specific Transcription	1.00000000000129	1.2894445157502e-12	18	0	0	232	10287
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	1.00000000000129	1.2894445157502e-12	18	0	0	232	10287
R-HSA-73780	RNA Polymerase III Chain Elongation	1.00000000000129	1.2894445157502e-12	18	0	0	232	10287
R-HSA-1482925	Acyl chain remodelling of PG	1.00000000000129	1.2894445157502e-12	18	0	0	232	10287
R-HSA-75953	RNA Polymerase II Transcription Initiation	1.00000000000158	1.58273106750448e-12	47	0	0	232	10287
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	1.00000000000158	1.58273106750448e-12	47	0	0	232	10287
R-HSA-167161	HIV Transcription Initiation	1.00000000000158	1.58273106750448e-12	47	0	0	232	10287
R-HSA-73776	RNA Polymerase II Promoter Escape	1.00000000000158	1.58273106750448e-12	47	0	0	232	10287
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	1.00000000000158	1.58273106750448e-12	47	0	0	232	10287
R-HSA-1912422	Pre-NOTCH Expression and Processing	1.00000000000158	1.58273106750448e-12	47	0	0	232	10287
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	1.00000000000158	1.58273106750448e-12	47	0	0	232	10287
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	1.00000000000159	1.58959738562658e-12	81	0	0	232	10287
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	1.00000000000174	1.74465039515458e-12	61	0	0	232	10287
R-HSA-72702	Ribosomal scanning and start codon recognition	1.00000000000174	1.74465039515458e-12	61	0	0	232	10287
R-HSA-6802952	Signaling by BRAF and RAF fusions	1.00000000000174	1.74465039515458e-12	61	0	0	232	10287
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	1.00000000000174	1.74465039515458e-12	61	0	0	232	10287
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	1.00000000000174	1.74465039515458e-12	61	0	0	232	10287
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	1.00000000000174	1.74465039515458e-12	61	0	0	232	10287
R-HSA-5610783	Degradation of GLI2 by the proteasome	1.00000000000174	1.74465039515458e-12	61	0	0	232	10287
R-HSA-421270	Cell-cell junction organization	1.00000000000174	1.74465039515458e-12	61	0	0	232	10287
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	1.00000000000215	2.15294662404586e-12	69	0	0	232	10287
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	1.00000000000215	2.15294662404586e-12	69	0	0	232	10287
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	1.00000000000215	2.15294662404586e-12	69	0	0	232	10287
R-HSA-909733	Interferon alpha/beta signaling	1.00000000000215	2.15294662404586e-12	69	0	0	232	10287
R-HSA-68867	Assembly of the pre-replicative complex	1.00000000000215	2.15294662404586e-12	69	0	0	232	10287
R-HSA-5619084	ABC transporter disorders	1.00000000000215	2.15294662404586e-12	69	0	0	232	10287
R-HSA-1296053	Classical Kir channels	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-2408550	Metabolism of ingested H2SeO4 and H2SeO3 into H2Se	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-1296061	HCN channels	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-6807047	Cholesterol biosynthesis via desmosterol	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-379401	Dopamine clearance from the synaptic cleft	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-4551638	SUMOylation of chromatin organization proteins	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-176034	Interactions of Tat with host cellular proteins	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-8849474	PTK6 Activates STAT3	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-211163	AKT-mediated inactivation of FOXO1A	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-6807062	Cholesterol biosynthesis via lathosterol	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-390650	Histamine receptors	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-6803544	Ion influx/efflux at host-pathogen interface	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-417973	Adenosine P1 receptors	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-6802953	RAS signaling downstream of NF1 loss-of-function variants	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-75944	Transcription from mitochondrial promoters	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-173736	Alternative complement activation	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-888593	Reuptake of GABA	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-427975	Proton/oligopeptide cotransporters	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-140179	Amine Oxidase reactions	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-1855191	Synthesis of IPs in the nucleus	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-167060	NGF processing	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-447115	Interleukin-12 signaling	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-5603037	IRAK4 deficiency (TLR5)	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-442745	Activation of CaMK IV	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-8848584	Wax biosynthesis	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-1251932	PLCG1 events in ERBB2 signaling	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-173107	Binding and entry of HIV virion	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-69560	Transcriptional activation of p53 responsive genes	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-6783984	Glycine degradation	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-209905	Catecholamine biosynthesis	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-209563	Axonal growth stimulation	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-1369007	Mitochondrial ABC transporters	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-428776	Class II GLUTs	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-5083630	Defective LFNG causes SCDO3	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-8847453	Synthesis of PIPs in the nucleus	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-2473224	Antagonism of Activin by Follistatin	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-8935690	Miscellaneous digestion events	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-165158	Activation of AKT2	1.0000000000023	2.30287365989045e-12	4	0	0	232	10287
R-HSA-6803157	Antimicrobial peptides	1.00000000000242	2.41531454017521e-12	97	0	0	232	10287
R-HSA-425986	Sodium/Proton exchangers	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-72200	mRNA Editing: C to U Conversion	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-390696	Adrenoceptors	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-8854691	Interleukin-19, 20, 22, 24	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-2243919	Crosslinking of collagen fibrils	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-156587	Amino Acid conjugation	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-8876493	InlA-mediated entry of Listeria monocytogenes into host cells	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-428890	Role of Abl in Robo-Slit signaling	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-196025	Formation of annular gap junctions	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-2179392	EGFR Transactivation by Gastrin	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-2214320	Anchoring fibril formation	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-163765	ChREBP activates metabolic gene expression	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-194002	Glucocorticoid biosynthesis	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-391908	Prostanoid ligand receptors	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-112411	MAPK1 (ERK2) activation	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-419771	Opsins	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-75094	Formation of the Editosome	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-162592	Integration of provirus	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-2428933	SHC-related events triggered by IGF1R	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-189085	Digestion of dietary carbohydrate	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-1296052	Ca2+ activated K+ channels	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-1462054	Alpha-defensins	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-159424	Conjugation of carboxylic acids	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-1614558	Degradation of cysteine and homocysteine	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-1300642	Sperm Motility And Taxes	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-428543	Inactivation of Cdc42 and Rac	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-198693	AKT phosphorylates targets in the nucleus	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-447041	CHL1 interactions	1.00000000000247	2.46926639070403e-12	9	0	0	232	10287
R-HSA-5658442	Regulation of RAS by GAPs	1.00000000000274	2.73515574363291e-12	70	0	0	232	10287
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	1.00000000000274	2.73515574363291e-12	70	0	0	232	10287
R-HSA-380259	Loss of Nlp from mitotic centrosomes	1.00000000000348	3.47984506431004e-12	72	0	0	232	10287
R-HSA-69202	Cyclin E associated events during G1/S transition	1.00000000000348	3.47984506431004e-12	72	0	0	232	10287
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	1.00000000000348	3.47984506431004e-12	72	0	0	232	10287
R-HSA-69052	Switching of origins to a post-replicative state	1.00000000000348	3.47984506431004e-12	72	0	0	232	10287
R-HSA-68949	Orc1 removal from chromatin	1.00000000000348	3.47984506431004e-12	72	0	0	232	10287
R-HSA-168325	Viral Messenger RNA Synthesis	1.0000000000037	3.70470445753438e-12	43	0	0	232	10287
R-HSA-5696395	Formation of Incision Complex in GG-NER	1.0000000000037	3.70470445753438e-12	43	0	0	232	10287
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	1.0000000000037	3.70470445753438e-12	43	0	0	232	10287
R-HSA-75893	TNF signaling	1.0000000000037	3.70470445753438e-12	43	0	0	232	10287
R-HSA-375280	Amine ligand-binding receptors	1.0000000000037	3.70470445753438e-12	43	0	0	232	10287
R-HSA-933541	TRAF6 mediated IRF7 activation	1.00000000000408	4.08224752611109e-12	35	0	0	232	10287
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	1.00000000000408	4.08224752611109e-12	35	0	0	232	10287
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	1.00000000000408	4.08224752611109e-12	35	0	0	232	10287
R-HSA-6804757	Regulation of TP53 Degradation	1.00000000000408	4.08224752611109e-12	35	0	0	232	10287
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	1.00000000000408	4.08224752611109e-12	35	0	0	232	10287
R-HSA-5693537	Resolution of D-Loop Structures	1.00000000000408	4.08224752611109e-12	35	0	0	232	10287
R-HSA-113418	Formation of the Early Elongation Complex	1.00000000000408	4.08224752611109e-12	35	0	0	232	10287
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	1.00000000000408	4.08224752611109e-12	35	0	0	232	10287
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	1.00000000000408	4.08224752611109e-12	35	0	0	232	10287
R-HSA-8868773	rRNA processing in the nucleus and cytosol	1.00000000000434	4.33512196685505e-12	191	0	0	232	10287
R-HSA-5689896	Ovarian tumor domain proteases	1.00000000000462	4.62152481100549e-12	37	0	0	232	10287
R-HSA-176187	Activation of ATR in response to replication stress	1.00000000000462	4.62152481100549e-12	37	0	0	232	10287
R-HSA-168253	Host Interactions with Influenza Factors	1.00000000000463	4.62871637052487e-12	42	0	0	232	10287
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	1.00000000000463	4.62871637052487e-12	42	0	0	232	10287
R-HSA-373752	Netrin-1 signaling	1.00000000000463	4.62871637052487e-12	42	0	0	232	10287
R-HSA-1461957	Beta defensins	1.00000000000463	4.62871637052487e-12	42	0	0	232	10287
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	1.00000000000463	4.62871637052487e-12	42	0	0	232	10287
R-HSA-5619102	SLC transporter disorders	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-111471	Apoptotic factor-mediated response	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-162791	Attachment of GPI anchor to uPAR	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-426496	Post-transcriptional silencing by small RNAs	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-196791	Vitamin D (calciferol) metabolism	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-174577	Activation of C3 and C5	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-190371	FGFR3b ligand binding and activation	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-447043	Neurofascin interactions	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-3595172	Defective CHST3 causes SEDCJD	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-182218	Nef Mediated CD8 Down-regulation	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-174362	Transport and synthesis of PAPS	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-447038	NrCAM interactions	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-420597	Nectin/Necl  trans heterodimerization	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-75158	TRAIL  signaling	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-171319	Telomere Extension By Telomerase	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-448706	Interleukin-1 processing	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-199920	CREB phosphorylation	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-3595177	Defective CHSY1 causes TPBS	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-426117	Cation-coupled Chloride cotransporters	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-5603029	IkBA variant leads to EDA-ID	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-164843	2-LTR circle formation	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-429593	Inositol transporters	1.00000000000481	4.81325211690506e-12	7	0	0	232	10287
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	1.00000000000491	4.90843739362684e-12	100	0	0	232	10287
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	1.00000000000546	5.45981984075389e-12	73	0	0	232	10287
R-HSA-199992	trans-Golgi Network Vesicle Budding	1.00000000000546	5.45981984075389e-12	73	0	0	232	10287
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	1.00000000000546	5.45981984075389e-12	73	0	0	232	10287
R-HSA-3214841	PKMTs methylate histone lysines	1.00000000000546	5.45981984075389e-12	73	0	0	232	10287
R-HSA-421837	Clathrin derived vesicle budding	1.00000000000546	5.45981984075389e-12	73	0	0	232	10287
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	1.00000000000546	5.45981984075389e-12	73	0	0	232	10287
R-HSA-1169092	Activation of RAS in B cells	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-427652	Sodium-coupled phosphate cotransporters	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-112303	Electric Transmission Across Gap Junctions	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-71032	Propionyl-CoA catabolism	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-112307	Transmission across Electrical Synapses	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-5662702	Melanin biosynthesis	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-111469	SMAC-mediated apoptotic response	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-8866911	TFAP2 (AP-2) family regulates transcription of cell cycle factors	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-209931	Serotonin and melatonin biosynthesis	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-1306955	GRB7 events in ERBB2 signaling	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-426048	Arachidonate production from DAG	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-390651	Dopamine receptors	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-1300652	Sperm:Oocyte Membrane Binding	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-8869496	TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-111461	Cytochrome c-mediated apoptotic response	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-68911	G2 Phase	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-114516	Disinhibition of SNARE formation	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-390648	Muscarinic acetylcholine receptors	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-8849468	PTK6 Regulates Proteins Involved in RNA Processing	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-74713	IRS activation	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-391906	Leukotriene receptors	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-196819	Vitamin B1 (thiamin) metabolism	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-2142850	Hyaluronan biosynthesis and export	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-5683678	Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3)	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-203641	NOSTRIN mediated eNOS trafficking	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-111448	Activation of NOXA and translocation to mitochondria	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-446205	Synthesis of GDP-mannose	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-71262	Carnitine synthesis	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-2161517	Abacavir transmembrane transport	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-69478	G2/M DNA replication checkpoint	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-70370	Galactose catabolism	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-75157	FasL/ CD95L signaling	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-6785470	tRNA processing in the mitochondrion	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-8849473	PTK6 Expression	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-111463	SMAC binds to IAPs	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-1483226	Synthesis of PI	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-8853383	Lysosomal oligosaccharide catabolism	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-380095	Tachykinin receptors bind tachykinins	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-157881	Cyclin B2 mediated events	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-187024	NGF-independant TRKA activation	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-1614517	Sulfide oxidation to sulfate	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-8875513	MET interacts with TNS proteins	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-444209	Free fatty acid receptors	1.00000000000551	5.51406324984023e-12	5	0	0	232	10287
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	1.0000000000058	5.80320019605618e-12	99	0	0	232	10287
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-111447	Activation of BAD and translocation to mitochondria	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-5682910	LGI-ADAM interactions	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-68884	Mitotic Telophase/Cytokinesis	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-205043	NRIF signals cell death from the nucleus	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-5358508	Mismatch Repair	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-156581	Methylation	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-6785631	ERBB2 Regulates Cell Motility	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-69183	Processive synthesis on the lagging strand	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-69298	Association of licensing factors with the pre-replicative complex	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-3371568	Attenuation phase	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-5099900	WNT5A-dependent internalization of FZD4	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-391903	Eicosanoid ligand-binding receptors	1.00000000000582	5.8233866054622e-12	15	0	0	232	10287
R-HSA-1296067	Potassium transport channels	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-350864	Regulation of thyroid hormone activity	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-190827	Transport of connexins along the secretory pathway	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-1483248	Synthesis of PIPs at the ER membrane	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-111458	Formation of apoptosome	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-8849472	PTK6 Down-Regulation	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-139910	Activation of BMF and translocation to mitochondria	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-351200	Interconversion of polyamines	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-177539	Autointegration results in viral DNA circles	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-844455	The NLRP1 inflammasome	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-191650	Regulation of gap junction activity	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-380615	Serotonin clearance from the synaptic cleft	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-3249367	STAT6-mediated induction of chemokines	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-73927	Depurination	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-111446	Activation of BIM and translocation to mitochondria	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-193681	Ceramide signalling	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-5602571	TRAF3 deficiency - HSE	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-844615	The AIM2 inflammasome	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-163282	Mitochondrial transcription initiation	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-175567	Integration of viral DNA into host genomic DNA	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-5602680	MyD88 deficiency (TLR5)	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-977442	GABA A (rho) receptor activation	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-352238	Breakdown of the nuclear lamina	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-427589	Type II Na+/Pi cotransporters	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-1307965	betaKlotho-mediated ligand binding	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-5653890	Lactose synthesis	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-8875791	MET activates STAT3	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-379397	Enzymatic degradation of dopamine by COMT	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-198745	Signalling to STAT3	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-6806664	Metabolism of vitamin K	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-165181	Inhibition of TSC complex formation by PKB	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-8853336	Signaling by plasma membrane FGFR1 fusions	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-190704	Oligomerization of connexins into connexons	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-1299503	TWIK related potassium channel (TREK)	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-110331	Cleavage of the damaged purine	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-77108	Utilization of Ketone Bodies	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	1.00000000000586	5.85800698788409e-12	3	0	0	232	10287
R-HSA-2559585	Oncogene Induced Senescence	1.00000000000594	5.94170363486026e-12	32	0	0	232	10287
R-HSA-73863	RNA Polymerase I Transcription Termination	1.00000000000594	5.94170363486026e-12	32	0	0	232	10287
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	1.00000000000594	5.94170363486026e-12	32	0	0	232	10287
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	1.00000000000594	5.94170363486026e-12	32	0	0	232	10287
R-HSA-68962	Activation of the pre-replicative complex	1.00000000000594	5.94170363486026e-12	32	0	0	232	10287
R-HSA-69190	DNA strand elongation	1.00000000000594	5.94170363486026e-12	32	0	0	232	10287
R-HSA-69481	G2/M Checkpoints	1.00000000000596	5.95798859899963e-12	169	0	0	232	10287
R-HSA-5619507	Activation of HOX genes during differentiation	1.00000000000605	6.05161839514767e-12	126	0	0	232	10287
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	1.00000000000605	6.05161839514767e-12	126	0	0	232	10287
R-HSA-4641258	Degradation of DVL	1.00000000000651	6.50860999143111e-12	59	0	0	232	10287
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	1.00000000000688	6.88053540148956e-12	52	0	0	232	10287
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	1.00000000000688	6.88053540148956e-12	52	0	0	232	10287
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	1.00000000000688	6.88053540148956e-12	52	0	0	232	10287
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	1.00000000000688	6.88053540148956e-12	52	0	0	232	10287
R-HSA-2980766	Nuclear Envelope Breakdown	1.00000000000688	6.88053540148956e-12	52	0	0	232	10287
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	1.00000000000688	6.88053540148956e-12	52	0	0	232	10287
R-HSA-3214842	HDMs demethylate histones	1.00000000000688	6.88053540148956e-12	52	0	0	232	10287
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	1.00000000000705	7.04974643591325e-12	67	0	0	232	10287
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	1.00000000000705	7.04974643591325e-12	67	0	0	232	10287
R-HSA-1632852	Macroautophagy	1.00000000000705	7.04974643591325e-12	67	0	0	232	10287
R-HSA-69615	G1/S DNA Damage Checkpoints	1.00000000000705	7.04974643591325e-12	67	0	0	232	10287
R-HSA-8848021	Signaling by PTK6	1.00000000000705	7.04974643591325e-12	67	0	0	232	10287
R-HSA-168273	Influenza Viral RNA Transcription and Replication	1.00000000000731	7.31214919092409e-12	137	0	0	232	10287
R-HSA-211000	Gene Silencing by RNA	1.00000000000731	7.31214919092409e-12	137	0	0	232	10287
R-HSA-69618	Mitotic Spindle Checkpoint	1.00000000000767	7.67117228621711e-12	21	0	0	232	10287
R-HSA-210745	Regulation of gene expression in beta cells	1.00000000000767	7.67117228621711e-12	21	0	0	232	10287
R-HSA-2028269	Signaling by Hippo	1.00000000000767	7.67117228621711e-12	21	0	0	232	10287
R-HSA-6807004	Negative regulation of MET activity	1.00000000000767	7.67117228621711e-12	21	0	0	232	10287
R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	1.00000000000767	7.67117228621711e-12	21	0	0	232	10287
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	1.00000000000767	7.67117228621711e-12	21	0	0	232	10287
R-HSA-2022870	Chondroitin sulfate biosynthesis	1.00000000000767	7.67117228621711e-12	21	0	0	232	10287
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	1.00000000000767	7.67117228621711e-12	21	0	0	232	10287
R-HSA-5654688	SHC-mediated cascade:FGFR1	1.00000000000767	7.67117228621711e-12	21	0	0	232	10287
R-HSA-1181150	Signaling by NODAL	1.00000000000767	7.67117228621711e-12	21	0	0	232	10287
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	1.00000000000767	7.67117228621711e-12	21	0	0	232	10287
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	1.00000000000767	7.67117228621711e-12	21	0	0	232	10287
R-HSA-5423646	Aflatoxin activation and detoxification	1.00000000000767	7.67117228621711e-12	21	0	0	232	10287
R-HSA-68689	CDC6 association with the ORC:origin complex	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-3371378	Regulation by c-FLIP	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-2470946	Cohesin Loading onto Chromatin	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-1059683	Interleukin-6 signaling	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-2514853	Condensation of Prometaphase Chromosomes	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-1839122	Signaling by activated point mutants of FGFR1	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-193048	Androgen biosynthesis	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-2485179	Activation of the phototransduction cascade	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-5660526	Response to metal ions	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-196780	Biotin transport and metabolism	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-69416	Dimerization of procaspase-8	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-5661231	Metallothioneins bind metals	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-418889	Ligand-independent caspase activation via DCC	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-2022923	Dermatan sulfate biosynthesis	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-8851805	MET activates RAS signaling	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-549127	Organic cation transport	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-3296469	Defects in cobalamin (B12) metabolism	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-174414	Processive synthesis on the C-strand of the telomere	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-189451	Heme biosynthesis	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-937039	IRAK1 recruits IKK complex	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-211999	CYP2E1 reactions	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-73614	Pyrimidine salvage reactions	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-446107	Type I hemidesmosome assembly	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-376172	DSCAM interactions	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-174490	Membrane binding and targetting of GAG proteins	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-75072	mRNA Editing	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-5218900	CASP8 activity is inhibited	1.00000000000784	7.84226149613572e-12	11	0	0	232	10287
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	1.00000000000788	7.88203851394016e-12	40	0	0	232	10287
R-HSA-167290	Pausing and recovery of HIV elongation	1.00000000000788	7.88203851394016e-12	40	0	0	232	10287
R-HSA-168276	NS1 Mediated Effects on Host Pathways	1.00000000000788	7.88203851394016e-12	40	0	0	232	10287
R-HSA-1442490	Collagen degradation	1.00000000000788	7.88203851394016e-12	40	0	0	232	10287
R-HSA-167287	HIV elongation arrest and recovery	1.00000000000788	7.88203851394016e-12	40	0	0	232	10287
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	1.00000000000788	7.88203851394016e-12	40	0	0	232	10287
R-HSA-5675221	Negative regulation of MAPK pathway	1.00000000000788	7.88203851394016e-12	40	0	0	232	10287
R-HSA-109703	PKB-mediated events	1.00000000000788	7.88203851394016e-12	40	0	0	232	10287
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	1.00000000000789	7.88839309983392e-12	71	0	0	232	10287
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	1.00000000000789	7.88839309983392e-12	71	0	0	232	10287
R-HSA-73856	RNA Polymerase II Transcription Termination	1.00000000000789	7.88839309983392e-12	71	0	0	232	10287
R-HSA-72649	Translation initiation complex formation	1.00000000000829	8.2898033513305e-12	62	0	0	232	10287
R-HSA-6790901	rRNA modification in the nucleus and cytosol	1.00000000000829	8.2898033513305e-12	62	0	0	232	10287
R-HSA-8852135	Protein ubiquitination	1.00000000000829	8.2898033513305e-12	62	0	0	232	10287
R-HSA-72187	mRNA 3'-end processing	1.00000000000829	8.2898033513305e-12	62	0	0	232	10287
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	1.00000000000829	8.2898033513305e-12	62	0	0	232	10287
R-HSA-1268020	Mitochondrial protein import	1.00000000000829	8.2898033513305e-12	62	0	0	232	10287
R-HSA-5678895	Defective CFTR causes cystic fibrosis	1.00000000000829	8.2898033513305e-12	62	0	0	232	10287
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	1.00000000000857	8.56724529273138e-12	77	0	0	232	10287
R-HSA-167172	Transcription of the HIV genome	1.00000000000857	8.56724529273138e-12	77	0	0	232	10287
R-HSA-170834	Signaling by TGF-beta Receptor Complex	1.00000000000857	8.56724529273138e-12	77	0	0	232	10287
R-HSA-69304	Regulation of DNA replication	1.00000000000857	8.56724529273138e-12	77	0	0	232	10287
R-HSA-171306	Packaging Of Telomere Ends	1.00000000000858	8.58197617429569e-12	51	0	0	232	10287
R-HSA-6799198	Complex I biogenesis	1.00000000000858	8.58197617429569e-12	51	0	0	232	10287
R-HSA-1461973	Defensins	1.00000000000858	8.58197617429569e-12	51	0	0	232	10287
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	1.00000000000858	8.58197617429569e-12	51	0	0	232	10287
R-HSA-195253	Degradation of beta-catenin by the destruction complex	1.0000000000086	8.59846019888329e-12	83	0	0	232	10287
R-HSA-73848	Pyrimidine metabolism	1.00000000000865	8.64992691954233e-12	26	0	0	232	10287
R-HSA-379716	Cytosolic tRNA aminoacylation	1.00000000000865	8.64992691954233e-12	26	0	0	232	10287
R-HSA-1187000	Fertilization	1.00000000000865	8.64992691954233e-12	26	0	0	232	10287
R-HSA-3238698	WNT ligand biogenesis and trafficking	1.00000000000865	8.64992691954233e-12	26	0	0	232	10287
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	1.00000000000865	8.64992691954233e-12	26	0	0	232	10287
R-HSA-912694	Regulation of IFNA signaling	1.00000000000865	8.64992691954233e-12	26	0	0	232	10287
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	1.00000000000865	8.64992691954233e-12	26	0	0	232	10287
R-HSA-1474165	Reproduction	1.00000000000865	8.64992691954233e-12	26	0	0	232	10287
R-HSA-6806003	Regulation of TP53 Expression and Degradation	1.00000000000882	8.82213909491245e-12	36	0	0	232	10287
R-HSA-76046	RNA Polymerase III Transcription Initiation	1.00000000000882	8.82213909491245e-12	36	0	0	232	10287
R-HSA-177243	Interactions of Rev with host cellular proteins	1.00000000000882	8.82213909491245e-12	36	0	0	232	10287
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	1.00000000000882	8.82213909491245e-12	36	0	0	232	10287
R-HSA-432720	Lysosome Vesicle Biogenesis	1.00000000000882	8.82213909491245e-12	36	0	0	232	10287
R-HSA-2514856	The phototransduction cascade	1.00000000000882	8.82213909491245e-12	36	0	0	232	10287
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	1.00000000000882	8.82213909491245e-12	36	0	0	232	10287
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	1.00000000000882	8.82213909491245e-12	36	0	0	232	10287
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	1.00000000000882	8.82213909491245e-12	36	0	0	232	10287
R-HSA-176033	Interactions of Vpr with host cellular proteins	1.00000000000882	8.82213909491245e-12	36	0	0	232	10287
R-HSA-912446	Meiotic recombination	1.00000000000912	9.11937894616177e-12	88	0	0	232	10287
R-HSA-674695	RNA Polymerase II Pre-transcription Events	1.00000000000912	9.11937894616177e-12	88	0	0	232	10287
R-HSA-446728	Cell junction organization	1.00000000000912	9.11937894616177e-12	88	0	0	232	10287
R-HSA-5389840	Mitochondrial translation elongation	1.00000000000912	9.11937894616177e-12	88	0	0	232	10287
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	1.0000000000096	9.59618772354914e-12	87	0	0	232	10287
R-HSA-5419276	Mitochondrial translation termination	1.0000000000096	9.59618772354914e-12	87	0	0	232	10287
R-HSA-453276	Regulation of mitotic cell cycle	1.0000000000096	9.59618772354914e-12	87	0	0	232	10287
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	1.0000000000096	9.59618772354914e-12	87	0	0	232	10287
R-HSA-5368286	Mitochondrial translation initiation	1.0000000000096	9.59618772354914e-12	87	0	0	232	10287
R-HSA-5693607	Processing of DNA double-strand break ends	1.00000000000965	9.64747029874013e-12	98	0	0	232	10287
R-HSA-69300	Removal of licensing factors from origins	1.00000000000984	9.83523201003913e-12	74	0	0	232	10287
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	1.00000000000984	9.83523201003913e-12	74	0	0	232	10287
R-HSA-212300	PRC2 methylates histones and DNA	1.00000000000984	9.83523201003913e-12	74	0	0	232	10287
R-HSA-2299718	Condensation of Prophase Chromosomes	1.00000000000984	9.83523201003913e-12	74	0	0	232	10287
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	1.00000000001046	1.04644053587756e-11	85	0	0	232	10287
R-HSA-109606	Intrinsic Pathway for Apoptosis	1.00000000001163	1.16322681714742e-11	44	0	0	232	10287
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	1.00000000001163	1.16322681714742e-11	44	0	0	232	10287
R-HSA-180746	Nuclear import of Rev protein	1.00000000001177	1.17744253248667e-11	33	0	0	232	10287
R-HSA-186712	Regulation of beta-cell development	1.00000000001177	1.17744253248667e-11	33	0	0	232	10287
R-HSA-1222556	ROS, RNS production in phagocytes	1.00000000001177	1.17744253248667e-11	33	0	0	232	10287
R-HSA-5357905	Regulation of TNFR1 signaling	1.00000000001177	1.17744253248667e-11	33	0	0	232	10287
R-HSA-180910	Vpr-mediated nuclear import of PICs	1.00000000001177	1.17744253248667e-11	33	0	0	232	10287
R-HSA-5654726	Negative regulation of FGFR1 signaling	1.00000000001177	1.17744253248667e-11	33	0	0	232	10287
R-HSA-71064	Lysine catabolism	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-5689877	Josephin domain DUBs	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-4641265	Repression of WNT target genes	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-176974	Unwinding of DNA	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-2160916	Hyaluronan uptake and degradation	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-3371511	HSF1 activation	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-1433617	Regulation of signaling by NODAL	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-190373	FGFR1c ligand binding and activation	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-390666	Serotonin receptors	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-210990	PECAM1 interactions	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-203615	eNOS activation	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-8851680	Butyrophilin (BTN) family interactions	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-209822	Glycoprotein hormones	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-8866427	VLDLR internalisation and degradation	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-844456	The NLRP3 inflammasome	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-1236977	Endosomal/Vacuolar pathway	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-211958	Miscellaneous substrates	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-5578768	Physiological factors	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-73621	Pyrimidine catabolism	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-1839130	Signaling by activated point mutants of FGFR3	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-2033514	FGFR3 mutant receptor activation	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-166786	Creation of C4 and C2 activators	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-389359	CD28 dependent Vav1 pathway	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	1.0000000000118	1.17969191185498e-11	12	0	0	232	10287
R-HSA-3214815	HDACs deacetylate histones	1.00000000001245	1.24545164887129e-11	94	0	0	232	10287
R-HSA-5368287	Mitochondrial translation	1.00000000001245	1.24545164887129e-11	94	0	0	232	10287
R-HSA-189445	Metabolism of porphyrins	1.00000000001278	1.27771784544502e-11	17	0	0	232	10287
R-HSA-5656121	Translesion synthesis by POLI	1.00000000001278	1.27771784544502e-11	17	0	0	232	10287
R-HSA-435354	Zinc transporters	1.00000000001278	1.27771784544502e-11	17	0	0	232	10287
R-HSA-5655862	Translesion synthesis by POLK	1.00000000001278	1.27771784544502e-11	17	0	0	232	10287
R-HSA-3296482	Defects in vitamin and cofactor metabolism	1.00000000001278	1.27771784544502e-11	17	0	0	232	10287
R-HSA-193639	p75NTR signals via NF-kB	1.00000000001278	1.27771784544502e-11	17	0	0	232	10287
R-HSA-3232118	SUMOylation of transcription factors	1.00000000001278	1.27771784544502e-11	17	0	0	232	10287
R-HSA-192456	Digestion of dietary lipid	1.00000000001278	1.27771784544502e-11	17	0	0	232	10287
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	1.00000000001278	1.27771784544502e-11	17	0	0	232	10287
R-HSA-156711	Polo-like kinase mediated events	1.00000000001278	1.27771784544502e-11	17	0	0	232	10287
R-HSA-1482922	Acyl chain remodelling of PI	1.00000000001278	1.27771784544502e-11	17	0	0	232	10287
R-HSA-622312	Inflammasomes	1.00000000001278	1.27771784544502e-11	17	0	0	232	10287
R-HSA-2142845	Hyaluronan metabolism	1.00000000001278	1.27771784544502e-11	17	0	0	232	10287
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	1.00000000001278	1.27771784544502e-11	17	0	0	232	10287
R-HSA-196299	Beta-catenin phosphorylation cascade	1.00000000001278	1.27771784544502e-11	17	0	0	232	10287
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	1.00000000001278	1.27843520219485e-11	104	0	0	232	10287
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	1.00000000001283	1.28290378442417e-11	20	0	0	232	10287
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	1.00000000001283	1.28290378442417e-11	20	0	0	232	10287
R-HSA-6804760	Regulation of TP53 Activity through Methylation	1.00000000001283	1.28290378442417e-11	20	0	0	232	10287
R-HSA-8874081	MET activates PTK2 signaling	1.00000000001283	1.28290378442417e-11	20	0	0	232	10287
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	1.00000000001283	1.28290378442417e-11	20	0	0	232	10287
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	1.00000000001283	1.28290378442417e-11	20	0	0	232	10287
R-HSA-194223	HDL-mediated lipid transport	1.00000000001283	1.28290378442417e-11	20	0	0	232	10287
R-HSA-5654719	SHC-mediated cascade:FGFR4	1.00000000001283	1.28290378442417e-11	20	0	0	232	10287
R-HSA-69186	Lagging Strand Synthesis	1.00000000001283	1.28290378442417e-11	20	0	0	232	10287
R-HSA-5654706	FRS-mediated FGFR3 signaling	1.00000000001283	1.28290378442417e-11	20	0	0	232	10287
R-HSA-8876384	Listeria monocytogenes entry into host cells	1.00000000001283	1.28290378442417e-11	20	0	0	232	10287
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	1.0000000000129	1.28976650067882e-11	45	0	0	232	10287
R-HSA-379724	tRNA Aminoacylation	1.0000000000129	1.28976650067882e-11	45	0	0	232	10287
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	1.0000000000129	1.28976650067882e-11	45	0	0	232	10287
R-HSA-8854214	TBC/RABGAPs	1.0000000000129	1.28976650067882e-11	45	0	0	232	10287
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	1.0000000000129	1.28976650067882e-11	45	0	0	232	10287
R-HSA-427413	NoRC negatively regulates rRNA expression	1.00000000001301	1.30134546546577e-11	107	0	0	232	10287
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	1.00000000001337	1.33725286948526e-11	84	0	0	232	10287
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	1.00000000001343	1.34268728582835e-11	49	0	0	232	10287
R-HSA-6783783	Interleukin-10 signaling	1.00000000001343	1.34268728582835e-11	49	0	0	232	10287
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	1.00000000001343	1.34268728582835e-11	49	0	0	232	10287
R-HSA-1500620	Meiosis	1.00000000001455	1.4550895452672e-11	121	0	0	232	10287
R-HSA-2408522	Selenoamino acid metabolism	1.00000000001455	1.4550895452672e-11	121	0	0	232	10287
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	1.0000000000148	1.47993017463724e-11	93	0	0	232	10287
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	1.0000000000148	1.47993017463724e-11	93	0	0	232	10287
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	1.00000000001481	1.48056685673761e-11	27	0	0	232	10287
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	1.00000000001481	1.48056685673761e-11	27	0	0	232	10287
R-HSA-1482788	Acyl chain remodelling of PC	1.00000000001481	1.48056685673761e-11	27	0	0	232	10287
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	1.00000000001481	1.48056685673761e-11	27	0	0	232	10287
R-HSA-380994	ATF4 activates genes	1.00000000001481	1.48056685673761e-11	27	0	0	232	10287
R-HSA-114508	Effects of PIP2 hydrolysis	1.00000000001481	1.48056685673761e-11	27	0	0	232	10287
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	1.00000000001481	1.48056685673761e-11	27	0	0	232	10287
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	1.00000000001481	1.48056685673761e-11	27	0	0	232	10287
R-HSA-77387	Insulin receptor recycling	1.00000000001481	1.48056685673761e-11	27	0	0	232	10287
R-HSA-901042	Calnexin/calreticulin cycle	1.00000000001481	1.48056685673761e-11	27	0	0	232	10287
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	1.00000000001481	1.48056685673761e-11	27	0	0	232	10287
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	1.00000000001484	1.48352481753783e-11	247	0	0	232	10287
R-HSA-168255	Influenza Life Cycle	1.00000000001486	1.48648696169636e-11	146	0	0	232	10287
R-HSA-69563	p53-Dependent G1 DNA Damage Response	1.00000000001579	1.57905070421168e-11	65	0	0	232	10287
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	1.00000000001579	1.57905070421168e-11	65	0	0	232	10287
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	1.00000000001579	1.57905070421168e-11	65	0	0	232	10287
R-HSA-112382	Formation of RNA Pol II elongation complex	1.00000000001579	1.57905070421168e-11	65	0	0	232	10287
R-HSA-75955	RNA Polymerase II Transcription Elongation	1.00000000001579	1.57905070421168e-11	65	0	0	232	10287
R-HSA-5334118	DNA methylation	1.00000000001579	1.57905070421168e-11	65	0	0	232	10287
R-HSA-69473	G2/M DNA damage checkpoint	1.00000000001606	1.60598362153016e-11	95	0	0	232	10287
R-HSA-2408557	Selenocysteine synthesis	1.00000000001606	1.60598362153016e-11	95	0	0	232	10287
R-HSA-4641257	Degradation of AXIN	1.00000000001629	1.62909287978156e-11	56	0	0	232	10287
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	1.00000000001629	1.62909287978156e-11	56	0	0	232	10287
R-HSA-69541	Stabilization of p53	1.00000000001629	1.62909287978156e-11	56	0	0	232	10287
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	1.00000000001629	1.62909287978156e-11	56	0	0	232	10287
R-HSA-381038	XBP1(S) activates chaperone genes	1.00000000001629	1.62909287978156e-11	56	0	0	232	10287
R-HSA-72312	rRNA processing	1.00000000001668	1.66795098187315e-11	201	0	0	232	10287
R-HSA-69620	Cell Cycle Checkpoints	1.00000000001668	1.66795098187315e-11	201	0	0	232	10287
R-HSA-72172	mRNA Splicing	1.00000000001686	1.68648902701848e-11	195	0	0	232	10287
R-HSA-73857	RNA Polymerase II Transcription	1.00000000001698	1.69782112325357e-11	159	0	0	232	10287
R-HSA-68875	Mitotic Prophase	1.00000000001699	1.69935438836557e-11	141	0	0	232	10287
R-HSA-6802957	Oncogenic MAPK signaling	1.00000000001705	1.70509495646861e-11	75	0	0	232	10287
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	1.00000000001705	1.70509495646861e-11	75	0	0	232	10287
R-HSA-8854518	AURKA Activation by TPX2	1.00000000001705	1.70509495646861e-11	75	0	0	232	10287
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	1.00000000001705	1.70509495646861e-11	75	0	0	232	10287
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	1.00000000001712	1.71228486842911e-11	110	0	0	232	10287
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	1.00000000001712	1.71228486842911e-11	110	0	0	232	10287
R-HSA-73854	RNA Polymerase I Promoter Clearance	1.00000000001712	1.71228486842911e-11	110	0	0	232	10287
R-HSA-72165	mRNA Splicing - Minor Pathway	1.00000000001728	1.72811740709396e-11	53	0	0	232	10287
R-HSA-5620920	Cargo trafficking to the periciliary membrane	1.00000000001728	1.72811740709396e-11	53	0	0	232	10287
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	1.00000000001728	1.72811740709396e-11	53	0	0	232	10287
R-HSA-180534	Vpu mediated degradation of CD4	1.00000000001728	1.72811740709396e-11	53	0	0	232	10287
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	1.00000000001728	1.72811740709396e-11	53	0	0	232	10287
R-HSA-194441	Metabolism of non-coding RNA	1.00000000001728	1.72811740709396e-11	53	0	0	232	10287
R-HSA-191859	snRNP Assembly	1.00000000001728	1.72811740709396e-11	53	0	0	232	10287
R-HSA-611105	Respiratory electron transport	1.00000000001734	1.73411592679894e-11	92	0	0	232	10287
R-HSA-381119	Unfolded Protein Response (UPR)	1.00000000001734	1.73411592679894e-11	92	0	0	232	10287
R-HSA-156902	Peptide chain elongation	1.00000000001734	1.73411592679894e-11	92	0	0	232	10287
R-HSA-192823	Viral mRNA Translation	1.00000000001734	1.73411592679894e-11	92	0	0	232	10287
R-HSA-5689603	UCH proteinases	1.00000000001762	1.76210341078543e-11	105	0	0	232	10287
R-HSA-72689	Formation of a pool of free 40S subunits	1.00000000001762	1.76210341078543e-11	105	0	0	232	10287
R-HSA-72766	Translation	1.00000000001805	1.80489283433385e-11	162	0	0	232	10287
R-HSA-5687128	MAPK6/MAPK4 signaling	1.00000000001826	1.82572203722536e-11	90	0	0	232	10287
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	1.00000000001826	1.82572203722536e-11	90	0	0	232	10287
R-HSA-168254	Influenza Infection	1.00000000001891	1.89132149889373e-11	157	0	0	232	10287
R-HSA-5696398	Nucleotide Excision Repair	1.00000000001898	1.89765440246846e-11	112	0	0	232	10287
R-HSA-73864	RNA Polymerase I Transcription	1.00000000001898	1.89765440246846e-11	112	0	0	232	10287
R-HSA-69275	G2/M Transition	1.00000000001956	1.95632932793283e-11	182	0	0	232	10287
R-HSA-6782135	Dual incision in TC-NER	1.00000000002003	2.00296897846086e-11	66	0	0	232	10287
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	1.00000000002004	2.00435687145599e-11	91	0	0	232	10287
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	1.00000000002004	2.00435687145599e-11	91	0	0	232	10287
R-HSA-73777	RNA Polymerase I Chain Elongation	1.00000000002004	2.00435687145599e-11	91	0	0	232	10287
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	1.00000000002008	2.00835610440332e-11	54	0	0	232	10287
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	1.00000000002008	2.00835610440332e-11	54	0	0	232	10287
R-HSA-189200	Hexose transport	1.00000000002008	2.00835610440332e-11	54	0	0	232	10287
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	1.00000000002008	2.00835610440332e-11	54	0	0	232	10287
R-HSA-169911	Regulation of Apoptosis	1.00000000002008	2.00835610440332e-11	54	0	0	232	10287
R-HSA-1592230	Mitochondrial biogenesis	1.00000000002008	2.00835610440332e-11	54	0	0	232	10287
R-HSA-69610	p53-Independent DNA Damage Response	1.00000000002008	2.00835610440332e-11	54	0	0	232	10287
R-HSA-3214847	HATs acetylate histones	1.00000000002036	2.03627356134055e-11	143	0	0	232	10287
R-HSA-5693532	DNA Double-Strand Break Repair	1.00000000002039	2.03875911459396e-11	167	0	0	232	10287
R-HSA-5578749	Transcriptional regulation by small RNAs	1.00000000002039	2.03881805222791e-11	106	0	0	232	10287
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	1.00000000002065	2.06486721904996e-11	38	0	0	232	10287
R-HSA-5689901	Metalloprotease DUBs	1.00000000002065	2.06486721904996e-11	38	0	0	232	10287
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	1.00000000002065	2.06486721904996e-11	38	0	0	232	10287
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	1.00000000002065	2.06486721904996e-11	38	0	0	232	10287
R-HSA-162906	HIV Infection	1.00000000002067	2.06745794724437e-11	236	0	0	232	10287
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	1.00000000002101	2.10057587766002e-11	115	0	0	232	10287
R-HSA-4839726	Chromatin organization	1.00000000002153	2.15335137525617e-11	279	0	0	232	10287
R-HSA-3247509	Chromatin modifying enzymes	1.00000000002153	2.15335137525617e-11	279	0	0	232	10287
R-HSA-429914	Deadenylation-dependent mRNA decay	1.0000000000218	2.17980289983115e-11	57	0	0	232	10287
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	1.0000000000218	2.17980289983115e-11	57	0	0	232	10287
R-HSA-432722	Golgi Associated Vesicle Biogenesis	1.0000000000218	2.17980289983115e-11	57	0	0	232	10287
R-HSA-162909	Host Interactions of HIV factors	1.00000000002217	2.21652314613494e-11	134	0	0	232	10287
R-HSA-5693538	Homology Directed Repair	1.00000000002306	2.30616190956382e-11	138	0	0	232	10287
R-HSA-180585	Vif-mediated degradation of APOBEC3G	1.00000000002324	2.32361862426359e-11	55	0	0	232	10287
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	1.00000000002324	2.32361862426359e-11	55	0	0	232	10287
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	1.00000000002324	2.32361862426359e-11	55	0	0	232	10287
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	1.00000000002338	2.33822726588385e-11	58	0	0	232	10287
R-HSA-381070	IRE1alpha activates chaperones	1.00000000002338	2.33822726588385e-11	58	0	0	232	10287
R-HSA-453274	Mitotic G2-G2/M phases	1.00000000002361	2.36119382961521e-11	184	0	0	232	10287
R-HSA-5693606	DNA Double Strand Break Response	1.00000000002378	2.37756262140219e-11	76	0	0	232	10287
R-HSA-5619115	Disorders of transmembrane transporters	1.00000000002378	2.37756262140219e-11	76	0	0	232	10287
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	1.00000000002378	2.37756262140219e-11	76	0	0	232	10287
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	1.00000000002378	2.37756262140219e-11	76	0	0	232	10287
R-HSA-69206	G1/S Transition	1.00000000002379	2.3791031007397e-11	119	0	0	232	10287
R-HSA-69239	Synthesis of DNA	1.00000000002384	2.38417235145329e-11	101	0	0	232	10287
R-HSA-5607764	CLEC7A (Dectin-1) signaling	1.00000000002384	2.38417235145329e-11	101	0	0	232	10287
R-HSA-927802	Nonsense-Mediated Decay (NMD)	1.00000000002427	2.42715432138773e-11	120	0	0	232	10287
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	1.00000000002427	2.42715432138773e-11	120	0	0	232	10287
R-HSA-162599	Late Phase of HIV Life Cycle	1.00000000002488	2.4879191831546e-11	139	0	0	232	10287
R-HSA-69242	S Phase	1.00000000002539	2.53923777368533e-11	130	0	0	232	10287
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	1.00000000002635	2.63450683042401e-11	117	0	0	232	10287
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	1.00000000002635	2.63450683042401e-11	117	0	0	232	10287
R-HSA-2871837	FCERI mediated NF-kB activation	1.00000000002651	2.65070378276462e-11	79	0	0	232	10287
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	1.00000000002651	2.65070378276462e-11	79	0	0	232	10287
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	1.00000000002651	2.65070378276462e-11	79	0	0	232	10287
R-HSA-3214858	RMTs methylate histone arginines	1.00000000002651	2.65070378276462e-11	79	0	0	232	10287
R-HSA-1221632	Meiotic synapsis	1.00000000002651	2.65070378276462e-11	79	0	0	232	10287
R-HSA-162587	HIV Life Cycle	1.0000000000266	2.66025730764093e-11	152	0	0	232	10287
R-HSA-212165	Epigenetic regulation of gene expression	1.00000000002669	2.66930622248732e-11	151	0	0	232	10287
R-HSA-1852241	Organelle biogenesis and maintenance	1.00000000002683	2.68273575337033e-11	340	0	0	232	10287
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	1.0000000000269	2.69017340100499e-11	149	0	0	232	10287
R-HSA-69306	DNA Replication	1.00000000002773	2.77344606157113e-11	109	0	0	232	10287
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	1.00000000003087	3.08670187418286e-11	108	0	0	232	10287
R-HSA-5685942	HDR through Homologous Recombination (HRR)	1.00000000003225	3.22525504329701e-11	68	0	0	232	10287
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	1.00000000003225	3.22525504329701e-11	68	0	0	232	10287
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	1.00000000003225	3.22525504329701e-11	68	0	0	232	10287
R-HSA-1169091	Activation of NF-kappaB in B cells	1.00000000003225	3.22525504329701e-11	68	0	0	232	10287
R-HSA-72163	mRNA Splicing - Major Pathway	1.00000000003323	3.32325863615581e-11	187	0	0	232	10287
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	1.00000000003462	3.46188105983767e-11	132	0	0	232	10287
R-HSA-72613	Eukaryotic Translation Initiation	1.00000000003575	3.57500683622933e-11	125	0	0	232	10287
R-HSA-72737	Cap-dependent Translation Initiation	1.00000000003575	3.57500683622933e-11	125	0	0	232	10287
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	1.00000000003787	3.78659923761386e-11	179	0	0	232	10287
R-HSA-5617833	Cilium Assembly	1.00000000004027	4.02665349645217e-11	192	0	0	232	10287
